Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Colorectal Cancer	10/3298	1.4695522237614698E-8	1.7179065495771583E-5	0	0	167020.0	3012326.45533486	EEF1A1;IFITM3;LGALS3;PLAU;KRT8;CTSH;APOE;MFGE8;CTSD;HSPA1A
Prostatic Neoplasms	8/1554	5.0987445415999385E-8	2.980216184565164E-5	0	0	47.720569210866756	801.3088331539068	EEF1A1;LGALS3;PLAU;KRT8;CTSH;APOE;CTSD;HSPA1A
Neoplasm Metastasis	10/3920	8.28883348905714E-8	3.229882116235932E-5	0	0	160800.0	2621968.0568345045	EEF1A1;IFITM3;LGALS3;PLAU;KRT8;CTSH;APOE;MFGE8;CTSD;HSPA1A
Colon Carcinoma	8/2091	5.226178473551155E-7	1.527350658895325E-4	0	0	34.386941910705715	497.38700984062916	EEF1A1;IFITM3;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Inflammatory Bowel Diseases	6/911	1.576218672380713E-6	3.685199256026107E-4	0	0	31.632596685082873	422.6267330773148	EEF1A1;LGALS3;PLAU;KRT8;APOE;HSPA1A
Colorectal Carcinoma	8/2931	7.189827479150538E-6	8.958214241742268E-4	0	0	23.35545672254533	276.5950160585575	EEF1A1;IFITM3;LGALS3;PLAU;APOE;MFGE8;CTSD;HSPA1A
Dementia, Vascular	3/80	7.2468738579976E-6	8.958214241742268E-4	0	0	110.83302411873841	1311.702231925129	APOE;CTSD;HSPA1A
Aortic Aneurysm, Abdominal	4/288	8.259275916243407E-6	8.958214241742268E-4	0	0	46.25821596244131	541.4141917042328	LGALS3;PLAU;CTSH;APOE
Pancreatic Neoplasm	5/665	8.780696189786254E-6	8.958214241742268E-4	0	0	29.28787878787879	340.9974506951044	LGALS3;PLAU;KRT8;APOE;CTSD
Malignant tumor of colon	7/2001	9.073601772195103E-6	8.958214241742268E-4	0	0	21.058508859913072	244.4922626806481	EEF1A1;IFITM3;LGALS3;PLAU;KRT8;APOE;HSPA1A
Small cell carcinoma of lung	5/673	9.307480602255856E-6	8.958214241742268E-4	0	0	28.9251497005988	335.08895367039696	EEF1A1;LGALS3;PLAU;KRT8;HSPA1A
Hereditary Diffuse Gastric Cancer	4/300	9.704204314934023E-6	8.958214241742268E-4	0	0	44.35585585585586	511.9974854258671	EEF1A1;LGALS3;PLAU;KRT8
Pancreatitis, Chronic	4/302	9.962085983118006E-6	8.958214241742268E-4	0	0	44.053691275167786	507.3542067797722	LGALS3;KRT8;APOE;HSPA1A
Prostate carcinoma	8/3145	1.2368365548829058E-5	9.298041996865901E-4	0	0	21.489321007331846	242.83724642409777	EEF1A1;LGALS3;PLAU;KRT8;CTSH;APOE;CTSD;HSPA1A
Osteopenia	4/329	1.3962978941121157E-5	9.298041996865901E-4	0	0	40.33846153846154	450.9477394421588	KRT8;APOE;MFGE8;HSPA1A
Arterial Diseases, Common Carotid	2/12	1.4810308032958316E-5	9.298041996865901E-4	0	0	499.5	5554.533471892794	PLAU;APOE
External Carotid Artery Diseases	2/12	1.4810308032958316E-5	9.298041996865901E-4	0	0	499.5	5554.533471892794	PLAU;APOE
Internal Carotid Artery Diseases	2/12	1.4810308032958316E-5	9.298041996865901E-4	0	0	499.5	5554.533471892794	PLAU;APOE
Renal Cell Carcinoma	6/1348	1.5378113578290633E-5	9.298041996865901E-4	0	0	20.843517138599104	230.9996388450915	LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Ischemia	3/104	1.596140787437272E-5	9.298041996865901E-4	0	0	84.3946251768034	932.1670555715073	PLAU;APOE;MFGE8
Ovarian Carcinoma	7/2203	1.7295646789380104E-5	9.298041996865901E-4	0	0	18.906800242865817	207.31411812717926	EEF1A1;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Cerebral Amyloid Angiopathy, Hereditary	2/13	1.749845371523095E-5	9.298041996865901E-4	0	0	454.0681818181818	4973.589532784677	APOE;CTSD
Subcortical Infarction	2/14	2.0409450302584202E-5	9.70212220956353E-4	0	0	416.2083333333333	4494.8471043704	PLAU;APOE
Primary malignant neoplasm of lung	7/2268	2.1007049133318813E-5	9.70212220956353E-4	0	0	18.296181630546954	197.061814484479	EEF1A1;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Carcinoma, Cribriform	3/115	2.157871492289579E-5	9.70212220956353E-4	0	0	76.06377551020408	817.2142308784522	PLAU;KRT8;APOE
Carcinoma, Granular Cell	3/115	2.157871492289579E-5	9.70212220956353E-4	0	0	76.06377551020408	817.2142308784522	PLAU;KRT8;APOE
Adenocarcinoma, Basal Cell	3/117	2.272258390640195E-5	9.838037254290325E-4	0	0	74.7218045112782	798.936834932397	PLAU;KRT8;APOE
Adenocarcinoma, Oxyphilic	3/122	2.5755581547851202E-5	0.0010329217901505169	0	0	71.5642256902761	756.2090962829158	PLAU;KRT8;APOE
Amyloidosis	5/833	2.62023909425682E-5	0.0010329217901505169	0	0	23.142512077294686	244.1456315085007	PLAU;APOE;MFGE8;CTSD;HSPA1A
Stomach Neoplasms	5/835	2.6507830371698463E-5	0.0010329217901505169	0	0	23.08433734939759	243.26437173044215	EEF1A1;LGALS3;PLAU;KRT8;APOE
Adenocarcinoma, Tubular	3/125	2.769740057229128E-5	0.0010444600409357583	0	0	69.79391100702576	732.4293060553069	PLAU;KRT8;APOE
Mammary Neoplasms	7/2387	2.9546803174486146E-5	0.0010792165961225194	0	0	17.264705882352942	180.06285432632302	LGALS3;PLAU;KRT8;CTSH;APOE;MFGE8;CTSD
Malignant neoplasm of stomach	7/2398	3.046548132766736E-5	0.0010792165961225194	0	0	17.17454342673916	178.59663915641076	EEF1A1;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Liver carcinoma	8/3593	3.4292731722751715E-5	0.0011480463374693006	0	0	18.304044630404462	188.1761426023733	EEF1A1;LGALS3;PLAU;KRT8;CTSH;APOE;CTSD;HSPA1A
Malignant neoplasm of lung	7/2449	3.5045063210199106E-5	0.0011480463374693006	0	0	16.767130767130766	172.01191213490378	EEF1A1;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
melanoma	7/2454	3.5523603560856586E-5	0.0011480463374693006	0	0	16.728102438359898	171.38464861203244	EEF1A1;LGALS3;PLAU;APOE;MFGE8;CTSD;HSPA1A
Periodontal Diseases	3/137	3.6427073387120595E-5	0.0011480463374693006	0	0	63.505330490405115	649.037069792638	PLAU;APOE;CTSD
Carcinoma of lung	7/2476	3.769495724376652E-5	0.0011480463374693006	0	0	16.558255704063722	168.6621315204435	EEF1A1;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Amyloid angiopathy	2/19	3.830094710119993E-5	0.0011480463374693006	0	0	293.72058823529414	2987.1489367888853	APOE;CTSD
Crohn Disease	5/912	4.056580530844029E-5	0.0011750514647818643	0	0	21.039691289966925	212.76566822708298	LGALS3;PLAU;KRT8;APOE;HSPA1A
Ulcerative Colitis	5/915	4.121224127977454E-5	0.0011750514647818643	0	0	20.967032967032967	211.69941905149165	LGALS3;PLAU;KRT8;APOE;HSPA1A
Carcinoma of ampulla of Vater	2/20	4.2545300346497585E-5	0.0011841775263108493	0	0	277.3888888888889	2791.9028448786567	PLAU;APOE
Diabetes Mellitus, Insulin-Dependent	5/956	5.088308933581765E-5	0.0013833100333388564	0	0	20.019978969505782	197.9171101453603	LGALS3;PLAU;CTSH;APOE;HSPA1A
Carotid artery occlusion	2/24	6.173695322587491E-5	0.0016037888515788392	0	0	226.9090909090909	2199.345382715804	APOE;HSPA1A
Norrie disease	2/24	6.173695322587491E-5	0.0016037888515788392	0	0	226.9090909090909	2199.345382715804	PLAU;APOE
Liver Failure	3/176	7.681948834931392E-5	0.0019522169973988691	0	0	49.092485549132945	465.10477049698454	LGALS3;PLAU;KRT8
Carcinogenesis	8/4065	8.760583481295517E-5	0.0020988301088414717	0	0	15.709144688193247	146.76524412976073	EEF1A1;IFITM3;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Colorectal Neoplasms	5/1073	8.846789047078415E-5	0.0020988301088414717	0	0	17.717228464419474	165.35260581052614	EEF1A1;LGALS3;PLAU;CTSH;APOE
Acquired CJD	2/29	9.069521855500593E-5	0.0020988301088414717	0	0	184.84259259259258	1720.5159460048703	APOE;CTSD
Malignant neoplasm of pancreas	6/1846	9.286667924652733E-5	0.0020988301088414717	0	0	14.796195652173912	137.3729947372228	EEF1A1;LGALS3;PLAU;KRT8;CTSH;CTSD
Familial Alzheimer Disease (FAD)	3/188	9.343524119817163E-5	0.0020988301088414717	0	0	45.88030888030888	425.688607410352	PLAU;APOE;CTSD
Arteriosclerosis	5/1087	9.411704546613501E-5	0.0020988301088414717	0	0	17.475046210720887	162.0106533839965	LGALS3;PLAU;APOE;MFGE8;HSPA1A
Transient Ischemic Attack	3/191	9.79272891906597E-5	0.0020988301088414717	0	0	45.141337386018236	416.7125643109336	PLAU;APOE;HSPA1A
Pancreatic carcinoma	6/1869	9.961384366140538E-5	0.0020988301088414717	0	0	14.59500805152979	134.48146053396874	EEF1A1;LGALS3;PLAU;KRT8;CTSH;CTSD
Fibrosis, Liver	4/545	1.0048801488588082E-4	0.0020988301088414717	0	0	23.96672828096118	220.6250483375628	LGALS3;PLAU;KRT8;APOE
Squamous cell carcinoma	6/1876	1.0174444671089041E-4	0.0020988301088414717	0	0	14.53475935828877	133.61871592776433	LGALS3;PLAU;KRT8;APOE;MFGE8;CTSD
Major depression, single episode	2/31	1.0381978350160118E-4	0.0020988301088414717	0	0	172.07758620689654	1578.4425771666922	APOE;HSPA1A
Disseminated Malignant Neoplasm	3/195	1.0413357255158714E-4	0.0020988301088414717	0	0	44.191964285714285	405.23307082641094	LGALS3;PLAU;KRT8
Atherosclerosis	5/1134	1.1516471529093665E-4	0.002281822918222118	0	0	16.70593445527015	151.5085778112751	LGALS3;PLAU;APOE;MFGE8;HSPA1A
Carcinoma of bladder	5/1162	1.293400312598363E-4	0.0025199749423791442	0	0	16.27744165946413	145.73300493485675	LGALS3;KRT8;MFGE8;CTSD;HSPA1A
Lung Neoplasms	5/1177	1.3747211192337668E-4	0.0026345065383348745	0	0	16.05631399317406	142.7741808073634	LGALS3;PLAU;KRT8;CTSH;APOE
Hemorrhage	2/37	1.484593618046431E-4	0.0027991773217681906	0	0	142.53571428571428	1256.4807280914272	PLAU;APOE
Liver diseases	4/606	1.515051735484694E-4	0.00281126266473271	0	0	21.47065337763012	188.83205153376244	LGALS3;KRT8;APOE;HSPA1A
Malignant neoplasm of ovary	6/2026	1.5707184921854363E-4	0.002869015495882461	0	0	13.344059405940595	116.87804385506067	EEF1A1;LGALS3;PLAU;APOE;CTSD;HSPA1A
Bladder Neoplasm	5/1217	1.611098330106871E-4	0.0028974983813768187	0	0	15.493399339933994	135.3104292462201	LGALS3;PLAU;MFGE8;CTSD;HSPA1A
Tumor Progression	6/2090	1.8708866137530402E-4	0.0033137370476928846	0	0	12.888195777351248	110.63134368079201	LGALS3;PLAU;KRT8;CTSH;MFGE8;CTSD
Secondary malignant neoplasm of lymph node	5/1271	1.978929770334444E-4	0.003452789405255172	0	0	14.789889415481833	126.12498518001921	IFITM3;LGALS3;PLAU;APOE;CTSD
Malignant neoplasm of prostate	7/3239	2.2096584473308589E-4	0.0037986628307790796	0	0	12.098391089108912	101.83823623570997	EEF1A1;LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Alzheimer Disease, Late Onset	3/253	2.2477501649325975E-4	0.003808144844646676	0	0	33.84	284.2698941191327	PLAU;APOE;CTSD
Asthma	5/1313	2.307530630435035E-4	0.003853576152826508	0	0	14.282874617737003	119.60711173594824	LGALS3;PLAU;APOE;MFGE8;CTSD
Liver neoplasms	5/1321	2.374639032183715E-4	0.00389939682890048	0	0	14.189969604863222	118.42231942956819	PLAU;KRT8;CTSH;APOE;CTSD
Liver Cirrhosis	4/683	2.4016815370473443E-4	0.00389939682890048	0	0	18.960235640648012	158.01785057080718	LGALS3;PLAU;KRT8;APOE
Brain Ischemia	3/264	2.547728353244323E-4	0.004079855404030977	0	0	32.39573070607553	268.0791503578203	LGALS3;PLAU;APOE
Intracranial Hemorrhages	2/49	2.6130779010617516E-4	0.00412795684640701	0	0	106.07978723404256	875.1382563847486	PLAU;APOE
Lafora Disease	2/51	2.831546947100322E-4	0.004413437841547035	0	0	101.73979591836735	831.1650111787942	APOE;CTSD
Cerebral Ischemia	3/275	2.8726097241379587E-4	0.004418527325680623	0	0	31.06827731092437	253.36551238467206	PLAU;APOE;HSPA1A
Mental deterioration	2/53	3.0586608976532464E-4	0.004643603362800838	0	0	97.74019607843137	790.9491626745274	APOE;CTSD
Cerebral Infarction	3/283	3.1250356501736845E-4	0.004683547019298765	0	0	30.168367346938776	243.48571554874746	PLAU;APOE;HSPA1A
Astrocytoma	4/741	3.2826301142639956E-4	0.004857461523512166	0	0	17.415649027589325	139.70303181099348	LGALS3;PLAU;APOE;CTSD
Neurodegenerative Disorders	4/745	3.350937337429696E-4	0.0048965571843191434	0	0	17.31803868645974	138.56336388989425	APOE;MFGE8;CTSD;HSPA1A
Carotid Stenosis	2/56	3.4155103523569007E-4	0.004929298273957058	0	0	92.29629629629629	736.7102780343856	APOE;HSPA1A
Carotid Artery Diseases	2/57	3.538767443157693E-4	0.005044901391526029	0	0	90.61363636363636	720.0668690209761	PLAU;APOE
Kidney Failure	3/297	3.600618069155709E-4	0.005071231955232559	0	0	28.71137026239067	227.6591978300928	PLAU;APOE;HSPA1A
Senile Plaques	3/301	3.744611778187578E-4	0.0051940891524100965	0	0	28.320230105465004	223.44725059673567	LGALS3;APOE;CTSD
Angina Pectoris	2/59	3.7917320411508265E-4	0.0051940891524100965	0	0	87.42543859649123	688.6954184966403	PLAU;APOE
Stomach Carcinoma	6/2378	3.848421371230503E-4	0.0051940891524100965	0	0	11.141231028667791	87.59990476228992	LGALS3;PLAU;KRT8;APOE;CTSD;HSPA1A
Breast Carcinoma	8/4963	3.920497083850321E-4	0.0051940891524100965	0	0	12.1372351160444	95.20595201113703	EEF1A1;LGALS3;PLAU;KRT8;APOE;MFGE8;CTSD;HSPA1A
Fatty Liver, Alcoholic	2/60	3.9214360539410807E-4	0.0051940891524100965	0	0	85.91379310344827	673.8976935048315	LGALS3;PLAU
Colonic Neoplasms	4/778	3.9544391322882686E-4	0.0051940891524100965	0	0	16.551248923341948	129.6873373071267	IFITM3;LGALS3;PLAU;HSPA1A
Kidney Failure, Acute	3/310	4.0821203017201287E-4	0.005302220703012034	0	0	27.47743136342485	214.42628610352446	LGALS3;APOE;HSPA1A
Cardiovascular Diseases	4/787	4.131828147264983E-4	0.0053078100045634785	0	0	16.35334184759472	127.41903214862444	LGALS3;PLAU;APOE;HSPA1A
Malignant neoplasm of breast	8/5054	4.487608158018061E-4	0.005702189061655558	0	0	11.846214823622672	91.32271311683415	EEF1A1;LGALS3;PLAU;KRT8;APOE;MFGE8;CTSD;HSPA1A
Diarrhea	3/329	4.857927447265171E-4	0.005968231407459919	0	0	25.851007887817705	197.23617102015228	LGALS3;KRT8;APOE
Schistosomiasis	2/67	4.889339976743091E-4	0.005968231407459919	0	0	76.63461538461539	584.2073646335838	LGALS3;APOE
Cerebral Hemorrhage	2/67	4.889339976743091E-4	0.005968231407459919	0	0	76.63461538461539	584.2073646335838	PLAU;APOE
Secondary malignant neoplasm of bone	3/330	4.901199444962808E-4	0.005968231407459919	0	0	25.770642201834864	196.39446695108356	LGALS3;APOE;CTSD
Non-alcoholic Fatty Liver Disease	3/334	5.076777246034338E-4	0.006118301650117671	0	0	25.454035390591283	193.08575258865798	EEF1A1;KRT8;APOE
Hepatitis B	4/839	5.271517390503703E-4	0.006288167172957988	0	0	15.293413173652695	115.4350209400162	LGALS3;PLAU;KRT8;APOE
Angina, Unstable	2/70	5.336190066674734E-4	0.006301016351457337	0	0	73.24264705882354	551.9440230421153	PLAU;APOE
Hallucinations	2/72	5.644733393963211E-4	0.006585207203511615	0	0	71.14285714285714	532.1213524698264	CTSH;APOE
Attention Deficit Disorder	2/73	5.802192831152235E-4	0.006585207203511615	0	0	70.13732394366197	522.670663979618	LGALS3;APOE
Bone neoplasms	2/73	5.802192831152235E-4	0.006585207203511615	0	0	70.13732394366197	522.670663979618	LGALS3;PLAU
Dysplastic Nevus	2/73	5.802192831152235E-4	0.006585207203511615	0	0	70.13732394366197	522.670663979618	LGALS3;CTSD
Pleural Effusion, Malignant	2/78	6.621298425578926E-4	0.007371712247144537	0	0	65.50657894736842	479.511360148814	PLAU;APOE
Pulmonary Embolism	2/78	6.621298425578926E-4	0.007371712247144537	0	0	65.50657894736842	479.511360148814	PLAU;APOE
Central neuroblastoma	5/1655	6.819986401726366E-4	0.007521286890205777	0	0	11.115151515151515	81.03482198548105	LGALS3;APOE;MFGE8;CTSD;HSPA1A
Prion Diseases	2/80	6.963752277821239E-4	0.007608062068012177	0	0	63.82051282051282	463.9509991068783	APOE;CTSD
Idiopathic Pulmonary Fibrosis	3/379	7.337715762375088E-4	0.007942397894644888	0	0	22.356382978723403	161.3530086276007	LGALS3;PLAU;KRT8
Neuroblastoma	5/1698	7.680772208848785E-4	0.008237452029490118	0	0	10.807442409923214	77.50687318186665	LGALS3;APOE;MFGE8;CTSD;HSPA1A
Alzheimer's Disease, Focal Onset	2/85	7.856794992100311E-4	0.008274408419608345	0	0	59.96084337349398	428.6577674110207	PLAU;APOE
Acute Confusional Senile Dementia	2/85	7.856794992100311E-4	0.008274408419608345	0	0	59.96084337349398	428.6577674110207	PLAU;APOE
Adenocarcinoma	5/1712	7.978213393085147E-4	0.008320521987379339	0	0	10.710603397773871	76.40543749408195	LGALS3;PLAU;KRT8;APOE;CTSD
ovarian neoplasm	4/938	8.042933999776435E-4	0.008320521987379339	0	0	13.6017130620985	96.91963795164328	EEF1A1;PLAU;APOE;CTSD
Ischemic stroke	3/394	8.213695390395627E-4	0.008422640273133762	0	0	21.482279868469128	152.6216616506191	PLAU;APOE;HSPA1A
Carcinoma, Transitional Cell	3/399	8.519913293487841E-4	0.008637032826240752	0	0	21.205627705627705	149.87998146287592	LGALS3;PLAU;HSPA1A
Creutzfeldt-Jakob disease	2/89	8.60907796340742E-4	0.008637032826240752	0	0	57.19252873563219	403.6375954618875	APOE;CTSD
Vascular Diseases	3/401	8.644421220446261E-4	0.008637032826240752	0	0	21.096913137114143	148.80551995986286	KRT8;APOE;HSPA1A
Acute Cerebrovascular Accidents	2/91	8.997797846246235E-4	0.008913920069713432	0	0	55.901685393258425	392.05867268618533	PLAU;APOE
Degenerative polyarthritis	4/976	9.34174911818691E-4	0.009152183802203073	0	0	13.043895747599452	90.99221926498446	LGALS3;PLAU;APOE;CTSD
Liver Cirrhosis, Alcoholic	2/93	9.394884997984335E-4	0.009152183802203073	0	0	54.667582417582416	381.04261518159007	PLAU;APOE
Sciatic Neuropathy	2/95	9.800325691035386E-4	0.009468248539520965	0	0	53.486559139784944	370.55085702120647	PLAU;APOE
Metabolic Diseases	3/421	9.95412545611273E-4	0.009509933164829386	0	0	20.066985645933013	138.71009421054535	LGALS3;APOE;HSPA1A
Aortic Aneurysm	2/96	0.0010006174330829893	0.009509933164829386	0	0	52.91489361702128	365.49047439590856	LGALS3;APOE
Adenoma	4/1000	0.0010235571889073898	0.009649502853489828	0	0	12.713520749665328	87.52586845093619	IFITM3;LGALS3;PLAU;APOE
Pulmonary Fibrosis	3/432	0.0010725590380541586	0.010017734339137238	0	0	19.541458541458542	133.6187846948968	LGALS3;PLAU;KRT8
Cirrhosis	3/433	0.0010797557970327562	0.010017734339137238	0	0	19.495016611295682	133.17085572702007	PLAU;KRT8;APOE
Severe Sepsis	2/103	0.0011505349815761979	0.01053403080639601	0	0	49.23019801980198	333.1667555276269	APOE;HSPA1A
Fatty Liver	3/443	0.0011534268119920354	0.01053403080639601	0	0	19.042207792207794	128.82087716020715	LGALS3;PLAU;APOE
Acute pancreatitis	2/104	0.0011727816519245243	0.01062776551240131	0	0	48.745098039215684	328.95029221317066	APOE;HSPA1A
Carotid Atherosclerosis	2/105	0.0011952352797267602	0.010747923400004482	0	0	48.269417475728154	324.82480811164004	PLAU;APOE
Abortion, Tubal	2/110	0.0013106018143653811	0.011519500157843086	0	0	46.023148148148145	305.4680074437484	LGALS3;APOE
Reperfusion Injury	2/110	0.0013106018143653811	0.011519500157843086	0	0	46.023148148148145	305.4680074437484	PLAU;HSPA1A
Post-Traumatic Stress Disorder	2/110	0.0013106018143653811	0.011519500157843086	0	0	46.023148148148145	305.4680074437484	APOE;MFGE8
Diabetes, Autoimmune	2/111	0.0013342936091659378	0.011640218127723742	0	0	45.59862385321101	301.8333994032146	LGALS3;CTSH
Cholera	2/112	0.0013581911701031112	0.011760929465559533	0	0	45.18181818181818	298.27235807102574	APOE;CTSD
Gingival Diseases	2/114	0.0014066029101133422	0.011948365575998455	0	0	44.370535714285715	291.36257325115224	APOE;CTSD
Glioblastoma	5/1937	0.0014077483088248866	0.011948365575998455	0	0	9.346790890269151	61.36882122828163	LGALS3;PLAU;APOE;CTSD;HSPA1A
Down Syndrome	3/475	0.0014104999567902368	0.011948365575998455	0	0	17.72215496368039	116.3248767249699	EEF1A1;KRT8;APOE
Alzheimer Disease, Early Onset	2/116	0.001455835676662768	0.012243682777113496	0	0	43.58771929824562	284.722618807131	PLAU;APOE
Multiple Sclerosis	4/1106	0.0014926564472916657	0.012463681334885408	0	0	11.426497277676951	74.35447904263533	LGALS3;CTSH;APOE;HSPA1A
Infarction, Middle Cerebral Artery	2/119	0.0015312212856459892	0.01260561748535325	0	0	42.46367521367522	275.23636354227165	PLAU;APOE
Muscle Rigidity	2/119	0.0015312212856459892	0.01260561748535325	0	0	42.46367521367522	275.23636354227165	APOE;CTSD
Infection	3/492	0.0015607153162988704	0.012691545821588109	0	0	17.091148115687993	110.45344227187334	LGALS3;PLAU;APOE
Alzheimer's Disease	5/1982	0.0015633726247294164	0.012691545821588109	0	0	9.111279716742539	58.867156890044626	PLAU;APOE;MFGE8;CTSD;HSPA1A
Pneumonia	3/497	0.0016067487658992037	0.012953719360939097	0	0	16.913823019086177	108.81579993752794	PLAU;APOE;HSPA1A
Malignant neoplasm of urinary bladder	4/1144	0.001692846196498293	0.01355436440894866	0	0	11.023391812865498	70.3440554987908	LGALS3;PLAU;CTSD;HSPA1A
Nodule	2/126	0.0017142674950731819	0.01363250817510578	0	0	40.05241935483871	255.08462303058462	LGALS3;CTSD
Renal glomerular disease	2/127	0.001741231214115014	0.0137533735763544	0	0	39.73	252.41115890469297	PLAU;APOE
Sarcomatoid Renal Cell Carcinoma	2/128	0.0017683979926759528	0.013874209754618718	0	0	39.41269841269841	249.7851189979635	KRT8;CTSD
Tauopathies	2/130	0.0018233400535626742	0.01411579154049514	0	0	38.79296875	244.6705616096702	APOE;HSPA1A
Aortic Valve Stenosis	2/130	0.0018233400535626742	0.01411579154049514	0	0	38.79296875	244.6705616096702	LGALS3;APOE
Sleep Apnea, Obstructive	2/132	0.0018790923323901791	0.014451703530027102	0	0	38.19230769230769	239.73183291162474	APOE;HSPA1A
Vesicular Stomatitis	2/133	0.0019072718827723631	0.014572554450724789	0	0	37.89885496183206	237.32571441911304	IFITM3;APOE
Adenocarcinoma of lung (disorder)	4/1187	0.0019415501235619398	0.014738130483401998	0	0	10.59847844463229	66.17974607692342	IFITM3;KRT8;APOE;CTSD
Middle Cerebral Artery Occlusion	2/135	0.001964236966804282	0.014814148478672294	0	0	37.32518796992481	232.63488584478782	PLAU;APOE
Amyotrophic Lateral Sclerosis, Sporadic	2/136	0.0019930221646429452	0.014934890451715404	0	0	37.04477611940298	230.34823784060453	APOE;CTSD
Spontaneous abortion	2/138	0.0020511970331448834	0.015176261593331448	0	0	36.49632352941177	225.8878535277181	LGALS3;APOE
Collecting Duct Carcinoma of the Kidney	2/138	0.0020511970331448834	0.015176261593331448	0	0	36.49632352941177	225.8878535277181	KRT8;CTSD
Neoplasms	4/1236	0.0022552769944393304	0.016507212281863578	0	0	10.1504329004329	61.861635454784285	LGALS3;PLAU;MFGE8;CTSD
Frontotemporal dementia	2/145	0.0022611384625046945	0.016507212281863578	0	0	34.69755244755245	211.37356341523795	APOE;CTSD
Diabetic Nephropathy	3/561	0.002273448398100972	0.016507212281863578	0	0	14.924731182795698	90.83874177549008	LGALS3;APOE;HSPA1A
Chromophobe Renal Cell Carcinoma	2/149	0.0023855095888930286	0.017213954996394755	0	0	33.74659863945578	203.77352124587753	KRT8;CTSD
Decreased platelet count	2/152	0.002480881956539845	0.017683847604848042	0	0	33.06666666666667	198.3716008384541	PLAU;APOE
Aneurysm	2/152	0.002480881956539845	0.017683847604848042	0	0	33.06666666666667	198.3716008384541	PLAU;APOE
Cervical Squamous Cell Carcinoma	2/153	0.00251307071970591	0.01780472528082551	0	0	32.84602649006622	196.6245221106688	APOE;CTSD
Glioma	5/2211	0.0025661941613935335	0.017938890959073115	0	0	8.061650045330916	48.09041373767223	LGALS3;PLAU;MFGE8;CTSD;HSPA1A
Focal glomerulosclerosis	2/155	0.002578044209687154	0.017938890959073115	0	0	32.41339869281046	193.20733082812885	PLAU;APOE
Other specified transient cerebral ischemias	2/155	0.002578044209687154	0.017938890959073115	0	0	32.41339869281046	193.20733082812885	PLAU;APOE
Cystic Fibrosis	3/594	0.002675929835151804	0.018340313529254172	0	0	14.06744017403916	83.32789606202643	PLAU;KRT8;APOE
Non-Small Cell Lung Carcinoma	5/2243	0.002737604649873782	0.018340313529254172	0	0	7.932082216264522	46.80461508862406	LGALS3;PLAU;KRT8;CTSD;HSPA1A
Nephritis	2/162	0.0028116916244772232	0.018340313529254172	0	0	30.984375	182.00125746513936	LGALS3;PLAU
TARSAL-CARPAL COALITION SYNDROME	2/165	0.0029147878179572105	0.018340313529254172	0	0	30.40950920245399	177.52944517411476	PLAU;KRT8
Anaplastic astrocytoma	2/166	0.0029495468813782112	0.018340313529254172	0	0	30.222560975609756	176.07977492674317	PLAU;CTSD
Sea-Blue Histiocyte Syndrome	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Mixed dementia	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Giant cell carcinoma of lung	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	PLAU
Sleep-wake cycle disturbance	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Mydriasis	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Speech Sound Disorders	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Cerebrovascular Occlusion	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	PLAU
Subcortical Vascular Dementia	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Tension Headache	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Idiopathic normal pressure hydrocephalus (INPH)	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Intracranial Atherosclerosis	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Dementia in Parkinson's disease	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Posterior Fossa Hemorrhage	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	PLAU
Iodine deficiency syndrome	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Primary Cutaneous B-Cell Non-Hodgkin Lymphoma	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
LIPOPROTEIN GLOMERULOPATHY	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Localized amyloidosis	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Arcus juvenilis	1/6	0.002996578172872153	0.018340313529254172	0	0	444.1111111111111	2580.4117942926405	APOE
Papillary Renal Cell Carcinoma	2/169	0.003055002759676999	0.018600511594075064	0	0	29.6751497005988	171.84804359874045	KRT8;CTSD
Blood Coagulation Disorders	2/171	0.003126287270313291	0.018935905797907965	0	0	29.321005917159763	169.1208984373564	PLAU;APOE
Prostatic Intraepithelial Neoplasias	2/174	0.0032346816302637597	0.01949145786483678	0	0	28.805232558139537	165.16415594776484	PLAU;KRT8
Cerebrovascular Disorders	2/178	0.0033819400511227505	0.019834549530568134	0	0	28.144886363636363	160.12486394918403	PLAU;APOE
Brain Neoplasms	3/646	0.0033960961837771115	0.019834549530568134	0	0	12.895134414574539	73.31049859935835	LGALS3;PLAU;APOE
Epilepsy, Temporal Lobe	2/181	0.0034944275793987057	0.019834549530568134	0	0	27.66899441340782	156.51203811645684	APOE;CTSD
Memory performance	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
Fat redistribution	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
NADH cytochrome B5 reductase deficiency	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
Cerebral Atherosclerosis	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
Pneumonia, Viral	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	IFITM3
colon (non-specific) lesion	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	LGALS3
Absent axillary hair	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
Postoperative confusion	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
Arcus Senilis	1/7	0.0034952242970889957	0.019834549530568134	0	0	370.0740740740741	2093.271349114512	APOE
Neoplasm Invasiveness	2/183	0.0035703900039385323	0.020163216978763984	0	0	27.36049723756906	154.1786029312998	PLAU;CTSD
Amyotrophic Lateral Sclerosis	3/660	0.003608592974193729	0.020210270474055773	0	0	12.611219830397912	70.93101572276082	LGALS3;APOE;CTSD
Autistic Disorder	3/677	0.0038775279345663514	0.020210270474055773	0	0	12.282323018228062	68.19830428462083	APOE;MFGE8;CTSD
Malignant Neoplasms	4/1438	0.003930920054824798	0.020210270474055773	0	0	8.626685262668527	47.78218973569863	IFITM3;LGALS3;CTSD;HSPA1A
Amyloidosis, Primary Cutaneous	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Aphasia, Progressive	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Felty Syndrome	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	EEF1A1
Sensory denervation disorder	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Macular Degeneration, Age-Related, 1	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Neuronal lipopigments	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	CTSD
Old myocardial infarction	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
HYPERALPHALIPOPROTEINEMIA 1	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Common ventricle	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Vasogenic Brain Edema	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	PLAU
Vasogenic Cerebral Edema	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	PLAU
Increased neuronal autofluorescent lipopigment	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	CTSD
Cytotoxic Brain Edema	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	PLAU
Cytotoxic Cerebral Edema	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	PLAU
Pleural Mesothelioma	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	PLAU
Wernicke-Korsakoff Syndrome	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Xanthelasma of periocular region	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Xanthoma of periocular region	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Zoonoses	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	IFITM3
Alcohol Withdrawal Seizures	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Prodrome	1/8	0.0039936462613403625	0.020210270474055773	0	0	317.1904761904762	1751.8590547314027	APOE
Tuberous Sclerosis	2/197	0.004123755680320674	0.020778751682305464	0	0	25.378205128205128	139.35149488816708	PLAU;KRT8
Cardiac Arrest	2/201	0.004288773167621561	0.021345389275122598	0	0	24.863065326633166	135.54732981615194	APOE;CTSD
Melanocytic nevus	2/203	0.004372427586274313	0.021345389275122598	0	0	24.61318407960199	133.70956972525602	LGALS3;CTSD
Anaplastic carcinoma	2/204	0.004414540647712871	0.021345389275122598	0	0	24.49009900990099	132.80617000141103	EEF1A1;LGALS3
eyelids (symptom)	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	APOE
Keratitis, Herpetic	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	APOE
Glycogen storage disease type Ia	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	APOE
Cerebral Thrombosis	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	APOE
Ovarian cancer stage III	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	CTSD
Abnormal rapid eye movement sleep	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	CTSH
Aggressive Systemic Mastocytosis	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	MFGE8
Anuria	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	PLAU
Psychoticism	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	MFGE8
LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	APOE
Argyrophilic grain disease	1/9	0.004491844107510829	0.021345389275122598	0	0	277.52777777777777	1500.1741678966396	APOE
Adenoid Cystic Carcinoma	2/208	0.004584894802334956	0.021699360420767463	0	0	24.009708737864077	129.29199625590968	LGALS3;CTSD
Nonalcoholic Steatohepatitis	2/209	0.004627958010520711	0.0218148504608819	0	0	23.892512077294686	128.43753269506544	LGALS3;APOE
Diabetes Mellitus	4/1507	0.004660797972071459	0.021881416985347533	0	0	8.20004435573298	44.02250070306648	LGALS3;APOE;CTSD;HSPA1A
COPPER TOXICOSIS, IDIOPATHIC	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	KRT8
Bile Duct Neoplasms	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Mild dementia	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Severe dementia	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Hemoglobinuria, Paroxysmal	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	PLAU
Hallermann's Syndrome	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Chronic idiopathic pulmonary fibrosis	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	KRT8
clinical depression	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Pancreatic disorders (not diabetes)	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	KRT8
cortex bone disorders	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Polygenic hypercholesterolemia	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Intrauterine infection	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	LGALS3
Xanthoma tendinosum	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Dementia due to Alzheimer's disease (disorder)	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Dementia of frontal lobe type	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Dysphoric mood	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	APOE
Quebec platelet disorder	1/10	0.0049898178893478615	0.021928936513712968	0	0	246.679012345679	1307.4865498601448	PLAU
Invasive Ductal Breast Carcinoma	2/218	0.005024037108783727	0.021996626892015644	0	0	22.886574074074073	121.15057108803265	PLAU;CTSD
Status Epilepticus	2/221	0.005159455023478336	0.022505234785246922	0	0	22.569634703196346	118.87255792693317	PLAU;CTSD
Graft-vs-Host Disease	2/226	0.005388901759505493	0.02299271184619292	0	0	22.060267857142858	115.22990468921296	CTSH;HSPA1A
Malignant neoplasm of body of pancreas	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
malignant neoplasm of head of pancreas	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Malignant neoplasm of other specified sites of pancreas	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Malignant neoplasm of tail of pancreas	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Eyelid Xanthoma	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Hypersensitive syndrome	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Postherpetic neuralgia	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Diabetic macular edema	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	CTSD
Primary Progressive Nonfluent Aphasia	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Apraxia of Phonation	1/11	0.005487567669022947	0.02299271184619292	0	0	222.0	1155.5699775561973	APOE
Cerebrovascular accident	3/768	0.0055279044623619015	0.023000648642210172	0	0	10.7703081232493	55.98348514565398	PLAU;APOE;HSPA1A
Seminoma	2/229	0.005528812890043678	0.023000648642210172	0	0	21.765418502202643	113.13190385973056	EEF1A1;PLAU
Ductal Carcinoma	2/230	0.005575822824266927	0.023113960572936302	0	0	21.66885964912281	112.4465466600682	KRT8;MFGE8
Hamman-Rich syndrome	2/233	0.0057179690628394765	0.02324443294384785	0	0	21.384199134199132	110.43103223714621	LGALS3;KRT8
Encephalopathies	2/234	0.005765722758352402	0.02324443294384785	0	0	21.290948275862068	109.77239834986464	EEF1A1;APOE
Plaque, Amyloid	2/235	0.005813661994846784	0.02324443294384785	0	0	21.198497854077253	109.12021347392655	APOE;CTSD
Hepatitis C	3/783	0.005835194027151658	0.02324443294384785	0	0	10.554945054945055	54.29303049363137	PLAU;KRT8;APOE
Sarcoidosis	2/236	0.005861786616149536	0.02324443294384785	0	0	21.10683760683761	108.47438821214317	KRT8;HSPA1A
IGA Glomerulonephritis	2/237	0.00591009646129007	0.02324443294384785	0	0	21.01595744680851	107.83483479141834	PLAU;APOE
Periodontitis	2/237	0.00591009646129007	0.02324443294384785	0	0	21.01595744680851	107.83483479141834	APOE;MFGE8
Overweight	2/238	0.005958591372044102	0.02324443294384785	0	0	20.925847457627118	107.20146699970567	LGALS3;APOE
Alport Syndrome, X-Linked	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	APOE
Exaggerated startle response	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	CTSD
Cerebral Infarction, Left Hemisphere	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	PLAU
Cerebral Infarction, Right Hemisphere	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	PLAU
Cirrhosis, Cryptogenic	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	KRT8
Senile dementia	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	APOE
Hemarthrosis	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	PLAU
Decreased circulating high-density lipoprotein levels	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	APOE
Posterior Choroidal Artery Infarction	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	PLAU
Progressive multiple sclerosis	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	APOE
Anterior Choroidal Artery Infarction	1/12	0.00598509351248777	0.02324443294384785	0	0	201.8080808080808	1032.9512945731403	PLAU
Hypercholesterolemia	2/240	0.006056135756416981	0.023365091416671455	0	0	20.747899159663866	105.95295110838458	LGALS3;APOE
Allergic disposition	2/240	0.006056135756416981	0.023365091416671455	0	0	20.747899159663866	105.95295110838458	LGALS3;PLAU
Vitiligo	2/243	0.00620383635894607	0.02375523614480041	0	0	20.486514522821576	104.12450080316117	APOE;HSPA1A
Liver Cirrhosis, Experimental	3/801	0.006217517260213673	0.02375523614480041	0	0	10.30719656283566	52.36452275112241	LGALS3;PLAU;KRT8
Acute myocardial infarction	2/247	0.006403347362334636	0.02375523614480041	0	0	20.147959183673468	101.76602013024588	PLAU;APOE
Diabetic Retinopathy	2/247	0.006403347362334636	0.02375523614480041	0	0	20.147959183673468	101.76602013024588	APOE;CTSD
Macular retinal edema	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Angina Pectoris, Variant	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Restrictive behavior	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Mediastinal lymphadenopathy	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Cystadenoma, Mucinous	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	PLAU
Hallucinations, Visual	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
obsolete Combined hyperlipidemia	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Influenza A virus infection	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	IFITM3
Age-related cognitive decline	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Lecithin Acyltransferase Deficiency	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Proximal spinal muscular atrophy	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Low density lipoprotein increased	1/13	0.006482395492037067	0.02375523614480041	0	0	184.9814814814815	932.059746399125	APOE
Brain Diseases	2/250	0.006554907730494333	0.02394589730296211	0	0	19.901209677419356	100.05415234065943	EEF1A1;APOE
Skin Neoplasms	2/256	0.0068629654523426255	0.024799406480758023	0	0	19.4251968503937	96.76886461421591	LGALS3;KRT8
Adenoma of large intestine	2/258	0.006967109551598633	0.024799406480758023	0	0	19.271484375	95.71288397159331	PLAU;APOE
Familial hypobetalipoproteinemia	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	APOE
Semantic Dementia	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	APOE
Genital ulcers	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	APOE
Copper-Overload Cirrhosis	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	KRT8
Corticobasal degeneration	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	APOE
ALZHEIMER DISEASE 2	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	APOE
ARTERIAL TORTUOSITY SYNDROME	1/14	0.006979473680213335	0.024799406480758023	0	0	170.74358974358975	847.7046615380154	APOE
Endometrial Carcinoma	3/840	0.007097512856448671	0.025142401603601504	0	0	9.806963645673322	48.52496260489715	PLAU;APOE;CTSD
Renal Insufficiency	2/263	0.007230647683735679	0.025536637892105765	0	0	18.89750957854406	93.15388759987995	APOE;HSPA1A
Trichohepatoenteric Syndrome	2/267	0.007444736523287775	0.025705375337907056	0	0	18.608490566037737	91.1862187392679	KRT8;APOE
Adenocarcinoma of colon	2/267	0.007444736523287775	0.025705375337907056	0	0	18.608490566037737	91.1862187392679	LGALS3;PLAU
Recurrent hepatitis	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	APOE
Executive dysfunction	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	APOE
Meleda Disease	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	PLAU
Genital Herpes	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	APOE
Systolic hypertension	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	APOE
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	APOE
Left ventricular systolic dysfunction	1/15	0.0074763281564485876	0.025705375337907056	0	0	158.53968253968253	776.212425317664	APOE
Myopia	2/269	0.007552863613211814	0.02581665954340529	0	0	18.467228464419474	90.22771116804498	CTSH;APOE
Pancreatitis	2/269	0.007552863613211814	0.02581665954340529	0	0	18.467228464419474	90.22771116804498	KRT8;HSPA1A
Virus Diseases	3/875	0.007948569681560644	0.026937540656982836	0	0	9.39613368283093	45.428082110971374	IFITM3;LGALS3;APOE
Nephropathic cystinosis	1/16	0.00797295899684864	0.026937540656982836	0	0	147.96296296296296	714.9125872208035	CTSD
Neurofibrillary degeneration (morphologic abnormality)	1/16	0.00797295899684864	0.026937540656982836	0	0	147.96296296296296	714.9125872208035	APOE
Adult Neuronal Ceroid Lipofuscinosis	1/16	0.00797295899684864	0.026937540656982836	0	0	147.96296296296296	714.9125872208035	CTSD
Essential Hypertension	2/278	0.008048328927051084	0.027113822811881027	0	0	17.856884057971016	86.11108763446595	LGALS3;APOE
Congestive heart failure	3/884	0.008176941142808999	0.027467943091792298	0	0	9.295767796335333	44.679523597144666	LGALS3;APOE;HSPA1A
Experimental Organism Basal Cell Carcinoma	2/282	0.008273186786523267	0.02750191439443112	0	0	17.598214285714285	84.37878279313249	LGALS3;APOE
Squamous cell carcinoma of lung	2/283	0.008329846656493067	0.02750191439443112	0	0	17.534697508896798	83.95455761010562	PLAU;KRT8
Macroangiopathy	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Memory dysfunction	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Schistosomiasis mansoni	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Keratoconjunctivitis, Vernal	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	PLAU
Hyperkeratosis lenticularis perstans	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Alagille Syndrome	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Laryngeal cleft	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	PLAU
Psychological symptom	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Lipoprotein (a) measurement	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	APOE
Pulmonary Thromboembolisms	1/17	0.00846936628057759	0.02750191439443112	0	0	138.70833333333334	661.8190142974174	PLAU
Noninfiltrating Intraductal Carcinoma	2/287	0.008558263109008691	0.027713599929172186	0	0	17.285087719298247	82.2918484471722	LGALS3;PLAU
Coronary heart disease	3/913	0.008939674952606495	0.027948608157661495	0	0	8.985871271585557	42.38865561345812	PLAU;APOE;HSPA1A
Retinal ischemia	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	LGALS3
Infarction, Lacunar	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Smith-Lemli-Opitz Syndrome	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Stenosis	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Niemann-Pick Diseases	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Hyperlipoproteinemia Type III	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Compression of spinal cord	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Xanthomatosis	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Dental Plaque	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Diastrophic dysplasia	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Alexander Disease	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	KRT8
Primary Progressive Aphasia (disorder)	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	APOE
Late-Infantile Neuronal Ceroid Lipfuscinosis	1/18	0.008965550093347357	0.027948608157661495	0	0	130.54248366013073	615.425022203049	CTSD
Epithelioma	2/298	0.009201000407842809	0.028287738590768857	0	0	16.633445945945947	77.9849642233935	PLAU;KRT8
Fibrosarcoma	2/298	0.009201000407842809	0.028287738590768857	0	0	16.633445945945947	77.9849642233935	PLAU;HSPA1A
Rheumatoid Arthritis	4/1833	0.009400411312239896	0.028287738590768857	0	0	6.619646437032987	30.893902062343905	LGALS3;PLAU;APOE;CTSD
Atrophic retina	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	CTSD
Aneurysm, Dissecting	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Massive Osteolyses	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
CADASIL Syndrome	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Somnolence	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Cerebral Small Vessel Diseases	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Thromboembolism	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	PLAU
Thrombosis of cerebral veins	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Dent's disease	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	CTSD
Lipidemias	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Aortic Rupture	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Pulmonary Infiltrate	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Lobular Neoplasia	1/19	0.009461510512395743	0.028287738590768857	0	0	123.28395061728395	574.5677163606151	APOE
Amnesia, Transient Global	1/20	0.009957247624386196	0.0293199558511523	0	0	116.78947368421052	538.3357753631753	CTSH
Cerebral Vasospasm	1/20	0.009957247624386196	0.0293199558511523	0	0	116.78947368421052	538.3357753631753	APOE
Cholesteryl Ester Transfer Protein Deficiency	1/20	0.009957247624386196	0.0293199558511523	0	0	116.78947368421052	538.3357753631753	APOE
Other Creutzfeldt-Jakob disease	1/20	0.009957247624386196	0.0293199558511523	0	0	116.78947368421052	538.3357753631753	CTSD
Idiopathic Nephrotic Syndrome	1/20	0.009957247624386196	0.0293199558511523	0	0	116.78947368421052	538.3357753631753	APOE
Dyslipoproteinemias	1/20	0.009957247624386196	0.0293199558511523	0	0	116.78947368421052	538.3357753631753	APOE
Myocardial Infarction	3/966	0.010441240394873532	0.030171057302156308	0	0	8.467734757454384	38.62973730555295	PLAU;APOE;CTSD
Asthma chronic	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	LGALS3
Shared Paranoid Disorder	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	APOE
Siderosis	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	APOE
Hypoalphalipoproteinemias	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	APOE
Pathological accumulation of air in tissues	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	APOE
Xanthoma	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	APOE
Amyloid nephropathy	1/21	0.010452761511867668	0.030171057302156308	0	0	110.94444444444444	506.0053047065427	APOE
Hepatitis, Toxic	2/325	0.010868261312522776	0.030765079542434168	0	0	15.222136222910217	68.83310783658636	LGALS3;APOE
Chemical and Drug Induced Liver Injury	2/325	0.010868261312522776	0.030765079542434168	0	0	15.222136222910217	68.83310783658636	LGALS3;APOE
Chemically-Induced Liver Toxicity	2/325	0.010868261312522776	0.030765079542434168	0	0	15.222136222910217	68.83310783658636	LGALS3;APOE
Heart Diseases	2/325	0.010868261312522776	0.030765079542434168	0	0	15.222136222910217	68.83310783658636	LGALS3;APOE
Drug-Induced Acute Liver Injury	2/325	0.010868261312522776	0.030765079542434168	0	0	15.222136222910217	68.83310783658636	LGALS3;APOE
Severe depression	1/22	0.010948052258043297	0.030765079542434168	0	0	105.65608465608466	476.99429568907004	APOE
Spastic syndrome	1/22	0.010948052258043297	0.030765079542434168	0	0	105.65608465608466	476.99429568907004	PLAU
Herpes zoster disease	1/22	0.010948052258043297	0.030765079542434168	0	0	105.65608465608466	476.99429568907004	APOE
Other specified manifestations of hyperkinetic syndrome	1/22	0.010948052258043297	0.030765079542434168	0	0	105.65608465608466	476.99429568907004	LGALS3
Wasting	1/22	0.010948052258043297	0.030765079542434168	0	0	105.65608465608466	476.99429568907004	EEF1A1
Angiomyolipoma of kidney	1/22	0.010948052258043297	0.030765079542434168	0	0	105.65608465608466	476.99429568907004	KRT8
Hepatitis, Drug-Induced	2/329	0.011125963288945565	0.030965294493182492	0	0	15.032874617737003	67.62499361239374	LGALS3;APOE
Schizophrenia	4/1923	0.011130843533454388	0.030965294493182492	0	0	6.277922529095015	28.23831731853235	IFITM3;APOE;MFGE8;HSPA1A
response to statin	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Exfoliation Syndrome	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Retinal Vein Occlusion	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Menorrhagia	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	PLAU
Camurati-Engelmann Syndrome	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Multi-infarct dementia	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Cellulitis of eyelid	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Cholesteatoma	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	CTSD
Hypobetalipoproteinemias	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Hypofibrinogenemia	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	PLAU
Hypoxic-Ischemic Encephalopathy	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Petechiae	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Andersen Syndrome	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Lipids measurement	1/23	0.01144311994957642	0.030965294493182492	0	0	100.84848484848484	450.8296990682604	APOE
Cerebral atrophy	2/338	0.011715770825303375	0.031629875507574234	0	0	14.623511904761905	65.02811659565542	APOE;CTSD
Thrombocytopenia	2/341	0.011915429053849031	0.03171700158469507	0	0	14.49188790560472	64.19792087449784	PLAU;APOE
Obesity	4/1961	0.011921667747162962	0.03171700158469507	0	0	6.143076136944303	27.21012740685898	LGALS3;APOE;CTSD;HSPA1A
Behavioral variant of frontotemporal dementia	1/24	0.011937964668319789	0.03171700158469507	0	0	96.45893719806763	427.1232267263204	APOE
Cognitive changes	1/24	0.011937964668319789	0.03171700158469507	0	0	96.45893719806763	427.1232267263204	APOE
Hyperlipoproteinemia Type IIb	1/24	0.011937964668319789	0.03171700158469507	0	0	96.45893719806763	427.1232267263204	APOE
Acute Lung Injury	1/24	0.011937964668319789	0.03171700158469507	0	0	96.45893719806763	427.1232267263204	PLAU
Endemic Cretinism	1/24	0.011937964668319789	0.03171700158469507	0	0	96.45893719806763	427.1232267263204	APOE
Ankylosing spondylitis	2/348	0.012387206632729476	0.03229709694439059	0	0	14.193641618497109	62.32557285007078	PLAU;HSPA1A
Encephalomyelitis	2/348	0.012387206632729476	0.03229709694439059	0	0	14.193641618497109	62.32557285007078	LGALS3;APOE
Dystonia, Primary	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Hydrocephalus, Normal Pressure	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Hallervorden-Spatz Syndrome	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Hepatic Form of Wilson Disease	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Tooth Attrition	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Type II Mucolipidosis	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	CTSD
Perianal Squamous Intraepithelial Neoplasia	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Quadriplegia	1/25	0.012432586505539576	0.03229709694439059	0	0	92.43518518518519	405.55330287566494	APOE
Primary malignant neoplasm	3/1032	0.012509989744619652	0.03242611532474583	0	0	7.897126197417743	34.599108633107086	LGALS3;CTSD;HSPA1A
Muscle Spasticity	2/353	0.01272923248727435	0.03278014338208809	0	0	13.987891737891738	61.041119548379285	APOE;CTSD
Schizophreniform Disorders	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	APOE
Blepharitis	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	APOE
Generalized pustular psoriasis	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	APOE
Carotid Artery Plaque	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	APOE
Tangier Disease	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	APOE
Increased drug resistance	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	KRT8
Indian childhood cirrhosis	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	KRT8
Zinc deficiency	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	HSPA1A
Dermatitis Herpetiformis	1/26	0.012926985542465876	0.03278014338208809	0	0	88.73333333333333	385.85142072369416	PLAU
Presenile dementia	2/362	0.013355401151062343	0.03359601332119327	0	0	13.631944444444445	58.83321470886943	PLAU;APOE
Mumps	1/27	0.013421161865694831	0.03359601332119327	0	0	85.31623931623932	367.79170199807675	HSPA1A
Corneal Diseases	1/27	0.013421161865694831	0.03359601332119327	0	0	85.31623931623932	367.79170199807675	APOE
Leg Ulcer	1/27	0.013421161865694831	0.03359601332119327	0	0	85.31623931623932	367.79170199807675	PLAU
Apathy	1/27	0.013421161865694831	0.03359601332119327	0	0	85.31623931623932	367.79170199807675	APOE
Aphasia	1/27	0.013421161865694831	0.03359601332119327	0	0	85.31623931623932	367.79170199807675	APOE
Autoimmune Diseases	3/1060	0.013455616448748237	0.033610289804672414	0	0	7.676577915934586	33.07345109883894	APOE;MFGE8;HSPA1A
Parkinson Disease	3/1064	0.013594051054972352	0.03388367949522959	0	0	7.646021273730981	32.863539928492905	APOE;CTSD;HSPA1A
Malignant Bone Neoplasm	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	PLAU
Benign Meningioma	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	LGALS3
Creutzfeldt-Jakob Disease, Sporadic	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	CTSD
Seborrheic keratosis	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	APOE
Hepatitis C Virus Infection	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	PLAU
Hyperemia	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	APOE
Agranulocytosis	1/28	0.01391511556314784	0.0341738867506719	0	0	82.1522633744856	351.18281785053944	HSPA1A
Gall Bladder Diseases	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	APOE
Cholesterol gallstones	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	APOE
Community acquired pneumonia	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	HSPA1A
Adult Fanconi syndrome	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	CTSD
Juvenile Neuronal Ceroid Lipofuscinosis	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	CTSD
Keratosis Follicularis	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	APOE
Disease of capillaries	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	APOE
Alveolar Bone Loss	1/29	0.014408846721137443	0.03470636031585722	0	0	79.21428571428571	335.8616722924233	MFGE8
Hyperinsulinism	2/377	0.014428820456378624	0.03470636031585722	0	0	13.076666666666666	55.425813262550776	CTSH;APOE
Drug-Induced Liver Disease	2/377	0.014428820456378624	0.03470636031585722	0	0	13.076666666666666	55.425813262550776	LGALS3;APOE
Chronic Kidney Diseases	2/380	0.014647939125745729	0.035161069482539546	0	0	12.970899470899472	54.78201836313573	APOE;HSPA1A
Age related macular degeneration	2/382	0.014794834592110081	0.03519364341845501	0	0	12.901315789473685	54.35939958291165	APOE;MFGE8
Mesothelioma	2/383	0.01486852679023259	0.03519364341845501	0	0	12.866797900262467	54.15002956665983	LGALS3;PLAU
Delirium, Dementia, Amnestic, Cognitive Disorders	1/30	0.014902355425265381	0.03519364341845501	0	0	76.47892720306514	321.6884165593148	APOE
Brain hemorrhage	1/30	0.014902355425265381	0.03519364341845501	0	0	76.47892720306514	321.6884165593148	PLAU
Serum cholesterol raised	1/30	0.014902355425265381	0.03519364341845501	0	0	76.47892720306514	321.6884165593148	APOE
Narcolepsy-Cataplexy Syndrome	1/30	0.014902355425265381	0.03519364341845501	0	0	76.47892720306514	321.6884165593148	CTSH
Welts	1/30	0.014902355425265381	0.03519364341845501	0	0	76.47892720306514	321.6884165593148	CTSD
Prostatic Hypertrophy	1/30	0.014902355425265381	0.03519364341845501	0	0	76.47892720306514	321.6884165593148	EEF1A1
Osteosarcoma	3/1103	0.014987955162275078	0.03532026334839399	0	0	7.35974025974026	30.914650706537312	LGALS3;PLAU;CTSD
Invasive carcinoma of breast	2/385	0.01501639938764056	0.03532026334839399	0	0	12.798302872062663	53.73511291464596	PLAU;CTSD
Hepatitis C, Chronic	2/386	0.015090579491747962	0.035423468726613186	0	0	12.764322916666666	53.52954450339459	KRT8;APOE
Chronic kidney disease stage 5	2/388	0.015239426581160799	0.0355681921396893	0	0	12.696891191709845	53.122133965076024	PLAU;APOE
Lupus Erythematosus, Systemic	3/1113	0.015358341804977683	0.0355681921396893	0	0	7.289575289575289	30.441969944367383	APOE;MFGE8;HSPA1A
Atherosclerosis of aorta	1/31	0.015395641764484845	0.0355681921396893	0	0	73.92592592592592	308.5424792813036	APOE
HIV Encephalopathy	1/31	0.015395641764484845	0.0355681921396893	0	0	73.92592592592592	308.5424792813036	APOE
Opportunistic Infections	1/31	0.015395641764484845	0.0355681921396893	0	0	73.92592592592592	308.5424792813036	APOE
AIDS-Associated Nephropathy	1/31	0.015395641764484845	0.0355681921396893	0	0	73.92592592592592	308.5424792813036	APOE
Progressive intrahepatic cholestasis (disorder)	1/31	0.015395641764484845	0.0355681921396893	0	0	73.92592592592592	308.5424792813036	APOE
Longevity	1/31	0.015395641764484845	0.0355681921396893	0	0	73.92592592592592	308.5424792813036	APOE
Carcinoma breast stage IV	2/392	0.0155390641805827	0.03582872983649147	0	0	12.564102564102564	52.32192554843263	PLAU;HSPA1A
Lung diseases	2/393	0.015614377609981132	0.03593151068123611	0	0	12.531329923273658	52.12485813816466	CTSH;CTSD
Ataxia Telangiectasia	2/396	0.01584128522833527	0.03613598659208279	0	0	12.434010152284264	51.54066009427227	LGALS3;PLAU
Bowen's Disease	1/32	0.015888705824063775	0.03613598659208279	0	0	71.53763440860214	296.3193797028303	APOE
Cataplexy	1/32	0.015888705824063775	0.03613598659208279	0	0	71.53763440860214	296.3193797028303	CTSH
HIV encephalitis	1/32	0.015888705824063775	0.03613598659208279	0	0	71.53763440860214	296.3193797028303	APOE
Lipid Metabolism Disorders	1/32	0.015888705824063775	0.03613598659208279	0	0	71.53763440860214	296.3193797028303	APOE
Aortic valve calcification	1/32	0.015888705824063775	0.03613598659208279	0	0	71.53763440860214	296.3193797028303	APOE
Gerstmann-Straussler-Scheinker Disease	1/33	0.016381547690707304	0.03682697932776315	0	0	69.29861111111111	284.9281499305533	APOE
Spastic	1/33	0.016381547690707304	0.03682697932776315	0	0	69.29861111111111	284.9281499305533	APOE
Harlequin Fetus	1/33	0.016381547690707304	0.03682697932776315	0	0	69.29861111111111	284.9281499305533	CTSD
Neuronal loss in central nervous system	1/33	0.016381547690707304	0.03682697932776315	0	0	69.29861111111111	284.9281499305533	CTSD
High altitude pulmonary edema	1/33	0.016381547690707304	0.03682697932776315	0	0	69.29861111111111	284.9281499305533	HSPA1A
Delusions	1/33	0.016381547690707304	0.03682697932776315	0	0	69.29861111111111	284.9281499305533	APOE
Amyotrophic Lateral Sclerosis, Guam Form	1/34	0.016874167453351394	0.037789083817945934	0	0	67.1952861952862	274.2892350890436	APOE
Secondary malignant neoplasm of pancreas	1/34	0.016874167453351394	0.037789083817945934	0	0	67.1952861952862	274.2892350890436	PLAU
Attention deficit hyperactivity disorder	2/412	0.017075817692554986	0.037946756476192264	0	0	11.939024390243903	48.592927495947386	LGALS3;APOE
Asthenozoospermia	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Excessive daytime somnolence	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	CTSH
Right Middle Cerebral Artery Infarction	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
COLORBLINDNESS, PARTIAL, DEUTAN SERIES	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	APOE
Embolic Infarction, Middle Cerebral Artery	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Middle Cerebral Artery Embolus	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Middle Cerebral Artery Syndrome	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Middle Cerebral Artery Thrombosis	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Multinodular goiter	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	LGALS3
Thrombotic Infarction, Middle Cerebral Artery	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Ventricular Fibrillation	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Left Middle Cerebral Artery Infarction	1/35	0.017366565196546502	0.037946756476192264	0	0	65.2156862745098	264.33277144453854	PLAU
Metastatic melanoma	2/417	0.017469961535622122	0.03810146461780273	0	0	11.792168674698795	47.72611830120704	LGALS3;PLAU
Exocrine pancreatic insufficiency	1/36	0.017858741011932532	0.03851820709031205	0	0	63.34920634920635	254.99716559529233	KRT8
Hepatitis E	1/36	0.017858741011932532	0.03851820709031205	0	0	63.34920634920635	254.99716559529233	APOE
Oestrogen deficiency	1/36	0.017858741011932532	0.03851820709031205	0	0	63.34920634920635	254.99716559529233	APOE
Paranoid Schizophrenia	1/36	0.017858741011932532	0.03851820709031205	0	0	63.34920634920635	254.99716559529233	HSPA1A
Peripheral arterial occlusive disease	1/36	0.017858741011932532	0.03851820709031205	0	0	63.34920634920635	254.99716559529233	APOE
Low Tension Glaucoma	1/36	0.017858741011932532	0.03851820709031205	0	0	63.34920634920635	254.99716559529233	APOE
Oculocerebrorenal Syndrome	1/37	0.01835069498318965	0.03943375447674393	0	0	61.58641975308642	246.22791539772206	CTSD
Leukoaraiosis	1/37	0.01835069498318965	0.03943375447674393	0	0	61.58641975308642	246.22791539772206	APOE
Autosomal Recessive Polycystic Kidney Disease	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	APOE
Neurobehavioral Manifestations	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	APOE
Comedone	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	LGALS3
Abnormality of the eye	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	APOE
Vitamin D Deficiency	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	APOE
Disorder of the optic nerve	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	APOE
End Stage Liver Disease	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	KRT8
Arteriovenous hemangioma	1/38	0.018842427200939708	0.03990361847445384	0	0	59.91891891891892	237.97662594437213	APOE
Kidney Failure, Chronic	2/437	0.01908581850895848	0.040345970772102106	0	0	11.238505747126437	44.49110563435897	PLAU;APOE
Meningioma	2/438	0.01916824815701136	0.040359595052700536	0	0	11.212155963302752	44.33847199819188	LGALS3;PLAU
Sense of smell impaired	1/39	0.019333937749796665	0.040359595052700536	0	0	58.33918128654971	230.20018425524987	APOE
heavy drinking	1/39	0.019333937749796665	0.040359595052700536	0	0	58.33918128654971	230.20018425524987	APOE
Stage IV Ovarian Carcinoma	1/39	0.019333937749796665	0.040359595052700536	0	0	58.33918128654971	230.20018425524987	PLAU
Neuronal Ceroid-Lipofuscinoses	1/39	0.019333937749796665	0.040359595052700536	0	0	58.33918128654971	230.20018425524987	CTSD
Optic Neuropathy	1/39	0.019333937749796665	0.040359595052700536	0	0	58.33918128654971	230.20018425524987	APOE
Anosmia	1/39	0.019333937749796665	0.040359595052700536	0	0	58.33918128654971	230.20018425524987	APOE
Childhood Acute Lymphoblastic Leukemia	2/443	0.019582716159050696	0.040806052031961255	0	0	11.082199546485262	43.58748692261313	PLAU;HSPA1A
Motor symptoms	1/40	0.019825226718581047	0.04096301502998809	0	0	56.84045584045584	222.86006355256757	APOE
Neoplasm Recurrence, Local	1/40	0.019825226718581047	0.04096301502998809	0	0	56.84045584045584	222.86006355256757	PLAU
AIDS Dementia Complex	1/40	0.019825226718581047	0.04096301502998809	0	0	56.84045584045584	222.86006355256757	APOE
Psychiatric symptom	1/40	0.019825226718581047	0.04096301502998809	0	0	56.84045584045584	222.86006355256757	APOE
Precancerous Conditions	2/446	0.019833247653527165	0.04096301502998809	0	0	11.00563063063063	43.14642562548976	PLAU;KRT8
Myocardial Ischemia	2/448	0.02000103740904889	0.041236706756927956	0	0	10.955156950672645	42.85625778489697	APOE;HSPA1A
Nephrotic Syndrome, Minimal Change	1/41	0.02031629419703573	0.041520538315270576	0	0	55.416666666666664	215.92173416578154	APOE
Hypoplastic Left Heart Syndrome	1/41	0.02031629419703573	0.041520538315270576	0	0	55.416666666666664	215.92173416578154	APOE
Alcohol withdrawal syndrome	1/41	0.02031629419703573	0.041520538315270576	0	0	55.416666666666664	215.92173416578154	APOE
Arterial Occlusive Diseases	1/41	0.02031629419703573	0.041520538315270576	0	0	55.416666666666664	215.92173416578154	PLAU
Endometrioid carcinoma ovary	1/41	0.02031629419703573	0.041520538315270576	0	0	55.416666666666664	215.92173416578154	KRT8
Cholangiocarcinoma	2/455	0.020593126928401494	0.04186496897316283	0	0	10.782008830022075	41.86436127652951	LGALS3;APOE
exudative macular degeneration	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	APOE
Ganglioneuroblastoma	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	LGALS3
Cerebral Edema	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	PLAU
Clear Cell Sarcoma of Soft Tissue	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	PLAU
Optic Neuritis	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	APOE
Disease due to Parvoviridae	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	LGALS3
Drug Allergy	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	HSPA1A
Aortic aneurysm without mention of rupture NOS	1/42	0.02080714026809889	0.04186496897316283	0	0	54.06233062330623	209.35416251688034	APOE
Hyperlipoproteinemias	1/43	0.0212977650246516	0.04248649712255584	0	0	52.77248677248677	203.12938317607103	APOE
Transient Cerebral Ischemia	1/43	0.0212977650246516	0.04248649712255584	0	0	52.77248677248677	203.12938317607103	APOE
intracranial glioma	1/43	0.0212977650246516	0.04248649712255584	0	0	52.77248677248677	203.12938317607103	PLAU
Depressive Syndrome	1/43	0.0212977650246516	0.04248649712255584	0	0	52.77248677248677	203.12938317607103	APOE
Dissection of aorta	1/43	0.0212977650246516	0.04248649712255584	0	0	52.77248677248677	203.12938317607103	APOE
Memory Disorders	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	APOE
Brittle diabetes	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	CTSH
Sickle Cell Trait	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	APOE
Intellectual disability, progressive	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	CTSD
Multiple Sclerosis, Acute Fulminating	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	APOE
HELLP Syndrome	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	PLAU
Neurocognitive Disorders	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	APOE
Apraxias	1/44	0.021788168551220757	0.042808381669340735	0	0	51.542635658914726	197.22213203300186	APOE
Diabetes	3/1268	0.021788697256850075	0.042808381669340735	0	0	6.3438735177865615	24.2739687294351	LGALS3;APOE;HSPA1A
Cerebral Amyloid Angiopathy	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Obesity, Visceral	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Abetalipoproteinemia	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Hypopituitarism	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Delirium	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Young onset Parkinson disease	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Lipoatrophy	1/45	0.022278350937474194	0.04318970521709342	0	0	50.36868686868687	191.60953052295554	APOE
Mammary Neoplasms, Human	2/476	0.022414018443180958	0.04330907034723726	0	0	10.29324894514768	39.094466562783396	KRT8;MFGE8
Thyroid Neoplasm	2/476	0.022414018443180958	0.04330907034723726	0	0	10.29324894514768	39.094466562783396	LGALS3;PLAU
Diabetes Mellitus, Ketosis-Prone	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	CTSH
Dysautonomia, Familial	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	APOE
Moyamoya disease 1	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	APOE
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	LGALS3
Sleep Apnea, Central	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	APOE
Thrombus	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	PLAU
Adult Diffuse Large B-Cell Lymphoma	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	LGALS3
Drusen	1/46	0.022768312266926525	0.043348898242939984	0	0	49.24691358024691	186.27081295676348	APOE
Cardiomyopathies	2/480	0.022768369137010393	0.043348898242939984	0	0	10.205020920502092	38.59929789734682	LGALS3;CTSD
Carcinoma, Pancreatic Ductal	1/47	0.023258052635139918	0.04392352751288944	0	0	48.17391304347826	181.18709015535833	HSPA1A
Serum triglycerides raised	1/47	0.023258052635139918	0.04392352751288944	0	0	48.17391304347826	181.18709015535833	APOE
FRAGILE X TREMOR/ATAXIA SYNDROME	1/47	0.023258052635139918	0.04392352751288944	0	0	48.17391304347826	181.18709015535833	APOE
Hemangioblastoma	1/47	0.023258052635139918	0.04392352751288944	0	0	48.17391304347826	181.18709015535833	PLAU
Protein measurement	1/47	0.023258052635139918	0.04392352751288944	0	0	48.17391304347826	181.18709015535833	LGALS3
Hyperglycemia	2/488	0.0234842106288948	0.04420527358566038	0	0	10.03292181069959	37.637773486439805	APOE;HSPA1A
Lymphoma	3/1307	0.023613518423763614	0.04420527358566038	0	0	6.141323400525854	23.005003900134497	PLAU;APOE;HSPA1A
Barrett Epithelium	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	CTSD
Fabry Disease	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	APOE
Sleep Disorders	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	APOE
Neuroblastic tumors	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	LGALS3
Corneal Neovascularization	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	APOE
Alcoholic Steatohepatitis	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	APOE
Psychotic symptom	1/48	0.0237475721230066	0.04420527358566038	0	0	47.146572104018915	176.3411440394006	APOE
Abnormality of vision	1/49	0.024236870821197704	0.04497286030155574	0	0	46.16203703703704	171.71724838044534	CTSH
Dryness of eye	1/49	0.024236870821197704	0.04497286030155574	0	0	46.16203703703704	171.71724838044534	LGALS3
Adult T-Cell Lymphoma/Leukemia	2/500	0.02457569018526242	0.04552928974100122	0	0	9.785140562248996	36.26370673962478	LGALS3;PLAU
Atypical Ductal Breast Hyperplasia	1/50	0.02472594881725805	0.04559090562677392	0	0	45.21768707482993	167.3010120823387	APOE
Moyamoya Disease	1/50	0.02472594881725805	0.04559090562677392	0	0	45.21768707482993	167.3010120823387	APOE
Varicella zoster	1/50	0.02472594881725805	0.04559090562677392	0	0	45.21768707482993	167.3010120823387	APOE
Herpes Simplex Infections	2/503	0.02485185828352848	0.045699392936603314	0	0	9.7250499001996	35.93233560849998	PLAU;APOE
Malignant Glioma	2/504	0.024944206022452262	0.045699392936603314	0	0	9.705179282868526	35.82292028281631	LGALS3;PLAU
Epistaxis	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	PLAU
Cockayne Syndrome, Type I	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	APOE
Frequent nosebleeds	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	PLAU
C-reactive protein measurement	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	APOE
Hematuria	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	PLAU
Hermanski-Pudlak Syndrome	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	LGALS3
Tardive Dyskinesia	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	APOE
Premature coronary artery disease	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	APOE
Drug-induced tardive dyskinesia	1/51	0.02521480619684272	0.045699392936603314	0	0	44.31111111111111	163.07924167915206	APOE
Secondary malignant neoplasm of liver	2/508	0.02531505186944684	0.04581005516313213	0	0	9.626482213438734	35.39037684374192	LGALS3;PLAU
Tumor Angiogenesis	2/511	0.025594710049855963	0.04615564504975379	0	0	9.568271119842828	35.07124996788323	LGALS3;PLAU
Malignant ascites	1/52	0.025703443051659298	0.04615564504975379	0	0	43.4400871459695	159.03982037824832	KRT8
Hippocampal sclerosis	1/52	0.025703443051659298	0.04615564504975379	0	0	43.4400871459695	159.03982037824832	APOE
Coronary Stenosis	1/52	0.025703443051659298	0.04615564504975379	0	0	43.4400871459695	159.03982037824832	APOE
Drug usage	1/52	0.025703443051659298	0.04615564504975379	0	0	43.4400871459695	159.03982037824832	APOE
Major Depressive Disorder	2/513	0.025781872402481632	0.04622547367868256	0	0	9.529843444227005	34.860964529140304	APOE;HSPA1A
Malignant neoplasm of large intestine	2/516	0.026063698554655408	0.046603171569352383	0	0	9.472762645914397	34.54917163230831	LGALS3;MFGE8
Unipolar Depression	2/517	0.026157928760530243	0.046603171569352383	0	0	9.45388349514563	34.446197615539056	APOE;HSPA1A
Other specified types of schizophrenia, unspecified	1/53	0.026191859470542787	0.046603171569352383	0	0	42.6025641025641	155.17160141847094	APOE
NEUROTICISM	1/53	0.026191859470542787	0.046603171569352383	0	0	42.6025641025641	155.17160141847094	APOE
Nodular glomerulosclerosis	1/53	0.026191859470542787	0.046603171569352383	0	0	42.6025641025641	155.17160141847094	APOE
Cerebral Aneurysm	1/54	0.026680055532623963	0.0473277464607548	0	0	41.79664570230608	151.46431378315344	APOE
Pancreatic Diseases	1/54	0.026680055532623963	0.0473277464607548	0	0	41.79664570230608	151.46431378315344	LGALS3
Polycystic Ovary Syndrome	2/526	0.02701245756326664	0.04768682977614151	0	0	9.287213740458014	33.54037426366609	APOE;HSPA1A
Atherogenesis	1/55	0.027168031335252564	0.04768682977614151	0	0	41.02057613168724	147.90847858667095	APOE
Bone pain	1/55	0.027168031335252564	0.04768682977614151	0	0	41.02057613168724	147.90847858667095	PLAU
Hallucinations, Sensory	1/55	0.027168031335252564	0.04768682977614151	0	0	41.02057613168724	147.90847858667095	CTSH
Ganglioneuroma	1/55	0.027168031335252564	0.04768682977614151	0	0	41.02057613168724	147.90847858667095	LGALS3
Hantavirus Infections	1/55	0.027168031335252564	0.04768682977614151	0	0	41.02057613168724	147.90847858667095	LGALS3
Primary central nervous system lymphoma	1/55	0.027168031335252564	0.04768682977614151	0	0	41.02057613168724	147.90847858667095	LGALS3
Atrophic	1/57	0.028143322503235813	0.04895765477125397	0	0	39.551587301587304	141.21677360109922	APOE
Malignant neoplasm of colon stage IV	1/57	0.028143322503235813	0.04895765477125397	0	0	39.551587301587304	141.21677360109922	LGALS3
Geographic Atrophy	1/57	0.028143322503235813	0.04895765477125397	0	0	39.551587301587304	141.21677360109922	APOE
Necrosis	1/57	0.028143322503235813	0.04895765477125397	0	0	39.551587301587304	141.21677360109922	LGALS3
Spondylarthropathies	1/57	0.028143322503235813	0.04895765477125397	0	0	39.551587301587304	141.21677360109922	HSPA1A
Respiratory Distress Syndrome, Newborn	1/57	0.028143322503235813	0.04895765477125397	0	0	39.551587301587304	141.21677360109922	HSPA1A
Retinoblastoma	2/539	0.028267147176921647	0.04909999264460833	0	0	9.056331471135941	32.29537635807571	PLAU;KRT8
SCHIZOPHRENIA 1 (disorder)	1/58	0.028630638041239193	0.049364625177298845	0	0	38.85575048732944	138.06527849839193	APOE
Mycoplasma Infections	1/58	0.028630638041239193	0.049364625177298845	0	0	38.85575048732944	138.06527849839193	EEF1A1
Heart valve disease	1/58	0.028630638041239193	0.049364625177298845	0	0	38.85575048732944	138.06527849839193	APOE
Inclusion Body Myositis (disorder)	1/58	0.028630638041239193	0.049364625177298845	0	0	38.85575048732944	138.06527849839193	APOE
Amnesia	1/58	0.028630638041239193	0.049364625177298845	0	0	38.85575048732944	138.06527849839193	APOE
Body fluid retention	1/59	0.02911773367114391	0.04981878582330457	0	0	38.18390804597701	135.03387352863817	APOE
Sleep Apnea Syndromes	1/59	0.02911773367114391	0.04981878582330457	0	0	38.18390804597701	135.03387352863817	APOE
Squamous cell carcinoma of mouth	1/59	0.02911773367114391	0.04981878582330457	0	0	38.18390804597701	135.03387352863817	PLAU
Anaplastic Oligodendroglioma	1/59	0.02911773367114391	0.04981878582330457	0	0	38.18390804597701	135.03387352863817	LGALS3
Drug Resistant Epilepsy	1/59	0.02911773367114391	0.04981878582330457	0	0	38.18390804597701	135.03387352863817	APOE
Metabolic Syndrome X	2/548	0.02914974294537239	0.04981878582330457	0	0	8.902930402930403	31.474611623023605	LGALS3;APOE
AURAL ATRESIA, CONGENITAL	1/60	0.02960460947305564	0.050302018130816924	0	0	37.534839924670436	132.1160756075347	APOE
Factor V Leiden mutation	1/60	0.02960460947305564	0.050302018130816924	0	0	37.534839924670436	132.1160756075347	APOE
Bullous pemphigoid	1/60	0.02960460947305564	0.050302018130816924	0	0	37.534839924670436	132.1160756075347	PLAU
Dry Eye Syndromes	1/60	0.02960460947305564	0.050302018130816924	0	0	37.534839924670436	132.1160756075347	LGALS3
Bile duct carcinoma	1/61	0.030091265543298037	0.050980709304515086	0	0	36.907407407407405	129.30585220246812	APOE
Bradykinesia	1/61	0.030091265543298037	0.050980709304515086	0	0	36.907407407407405	129.30585220246812	APOE
Systemic Scleroderma	2/562	0.030545120714532227	0.05158056795526627	0	0	8.674107142857142	30.26005925643647	PLAU;APOE
Macular degeneration	1/62	0.030577701961505156	0.05158056795526627	0	0	36.30054644808743	126.59758326788086	APOE
Pemphigus Vulgaris	1/62	0.030577701961505156	0.05158056795526627	0	0	36.30054644808743	126.59758326788086	PLAU
Lymphangioleiomyomatosis	1/63	0.031063918820932256	0.05195096008822576	0	0	35.71326164874552	123.9860268803296	PLAU
Brain Edema	1/63	0.031063918820932256	0.05195096008822576	0	0	35.71326164874552	123.9860268803296	PLAU
Inclusion Body Myopathy, Sporadic	1/63	0.031063918820932256	0.05195096008822576	0	0	35.71326164874552	123.9860268803296	APOE
gliosarcoma	1/63	0.031063918820932256	0.05195096008822576	0	0	35.71326164874552	123.9860268803296	PLAU
Neuro-degenerative disease	1/63	0.031063918820932256	0.05195096008822576	0	0	35.71326164874552	123.9860268803296	APOE
Viral hepatitis	1/63	0.031063918820932256	0.05195096008822576	0	0	35.71326164874552	123.9860268803296	APOE
Steatohepatitis	2/569	0.03125296107680428	0.05219244499826315	0	0	8.563932980599647	29.679518567652007	LGALS3;APOE
Papillary thyroid carcinoma	2/571	0.03145643506882848	0.0523889943835192	0	0	8.532952548330405	29.51677734843063	LGALS3;PLAU
Extrapyramidal sign	1/64	0.03154991620701242	0.0523889943835192	0	0	35.14462081128748	121.46628828977606	APOE
Febrile Convulsions	1/64	0.03154991620701242	0.0523889943835192	0	0	35.14462081128748	121.46628828977606	APOE
Mitral Valve Prolapse Syndrome	1/64	0.03154991620701242	0.0523889943835192	0	0	35.14462081128748	121.46628828977606	PLAU
Mammary Ductal Carcinoma	1/65	0.0320356942028436	0.052802794072325715	0	0	34.59375	119.03379191454992	MFGE8
HEMOCHROMATOSIS, TYPE 1	1/65	0.0320356942028436	0.052802794072325715	0	0	34.59375	119.03379191454992	APOE
Multiple, subcutaneous nodules	1/65	0.0320356942028436	0.052802794072325715	0	0	34.59375	119.03379191454992	APOE
Subcutaneous nodule	1/65	0.0320356942028436	0.052802794072325715	0	0	34.59375	119.03379191454992	APOE
Stress, Psychological	1/65	0.0320356942028436	0.052802794072325715	0	0	34.59375	119.03379191454992	APOE
Malignant neoplasm of endometrium	2/577	0.032070131558042135	0.052802794072325715	0	0	8.441304347826087	29.03665331130836	PLAU;CTSD
Uterine Corpus Cancer	2/579	0.03227578505041075	0.053066656433094474	0	0	8.411178509532062	28.87926007714143	PLAU;CTSD
GRN-related frontotemporal dementia	1/66	0.0325212529076381	0.05324558074093688	0	0	34.05982905982906	116.68425597420442	APOE
Thyroid Nodule	1/66	0.0325212529076381	0.05324558074093688	0	0	34.05982905982906	116.68425597420442	LGALS3
Congenital arteriovenous malformation	1/66	0.0325212529076381	0.05324558074093688	0	0	34.05982905982906	116.68425597420442	APOE
Tongue Carcinoma	1/67	0.03300659239380316	0.053739145554813225	0	0	33.54208754208754	114.41366955149839	LGALS3
Parasitemia	1/67	0.03300659239380316	0.053739145554813225	0	0	33.54208754208754	114.41366955149839	APOE
Pustulosis of Palms and Soles	1/67	0.03300659239380316	0.053739145554813225	0	0	33.54208754208754	114.41366955149839	APOE
Arteriopathic disease	1/67	0.03300659239380316	0.053739145554813225	0	0	33.54208754208754	114.41366955149839	APOE
Migraine with Aura	1/68	0.03349171276321553	0.054453146342418574	0	0	33.039800995024876	112.21827165973407	APOE
Hepatolenticular Degeneration	1/69	0.033976614095502004	0.054935908544456215	0	0	32.552287581699346	110.09453231300331	APOE
hiv-infection/aids	1/69	0.033976614095502004	0.054935908544456215	0	0	32.552287581699346	110.09453231300331	APOE
Diabetic Angiopathies	1/69	0.033976614095502004	0.054935908544456215	0	0	32.552287581699346	110.09453231300331	APOE
Progressive supranuclear palsy	1/69	0.033976614095502004	0.054935908544456215	0	0	32.552287581699346	110.09453231300331	APOE
Respiratory Tract Infections	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	PLAU
Brain Injuries, Focal	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	HSPA1A
Brain Injuries	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	HSPA1A
Brain Lacerations	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	HSPA1A
Glaucoma, Open-Angle	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	APOE
Injuries, Acute Brain	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	HSPA1A
Cooley's anemia	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	APOE
Pulmonary arterial hypertension	1/70	0.03446129648195661	0.05510978876526303	0	0	32.07890499194847	108.03913520130237	LGALS3
Tuberculosis	2/602	0.03467951042478483	0.055382988642859926	0	0	8.079166666666667	27.158977113806017	IFITM3;LGALS3
Rhabdoid Tumor	1/71	0.03494576000547686	0.055504882400003334	0	0	31.61904761904762	106.04896194083372	KRT8
Pediatric Obesity	1/71	0.03494576000547686	0.055504882400003334	0	0	31.61904761904762	106.04896194083372	APOE
Duodenal Ulcer	1/71	0.03494576000547686	0.055504882400003334	0	0	31.61904761904762	106.04896194083372	HSPA1A
Pterygium	1/71	0.03494576000547686	0.055504882400003334	0	0	31.61904761904762	106.04896194083372	PLAU
Spinocerebellar Ataxia Type 7	1/72	0.03543000476018619	0.05612151160522718	0	0	31.172143974960875	104.12107765370268	CTSD
Hyperuricemia	1/72	0.03543000476018619	0.05612151160522718	0	0	31.172143974960875	104.12107765370268	APOE
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	1/73	0.03591403083014349	0.05658153913805625	0	0	30.737654320987655	102.25271781730339	PLAU
Guillain-Barre Syndrome	1/73	0.03591403083014349	0.05658153913805625	0	0	30.737654320987655	102.25271781730339	APOE
Hypopigmentation disorder	1/73	0.03591403083014349	0.05658153913805625	0	0	30.737654320987655	102.25271781730339	HSPA1A
Urinary tract infection	1/73	0.03591403083014349	0.05658153913805625	0	0	30.737654320987655	102.25271781730339	PLAU
Shy-Drager Syndrome	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	APOE
Central Nervous System Neoplasms	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	LGALS3
MYOTONIC DYSTROPHY 1	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	CTSD
Comatose	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	APOE
Angiogenic Switch	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	LGALS3
Apnea	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	CTSD
Endometrial Hyperplasia	1/75	0.0368814272661001	0.057562601434006704	0	0	29.903903903903903	98.68429377205668	APOE
Machado-Joseph Disease	1/76	0.0373647978046119	0.05800723590118368	0	0	29.503703703703703	96.97944863399397	APOE
Stable angina	1/76	0.0373647978046119	0.05800723590118368	0	0	29.503703703703703	96.97944863399397	APOE
Acromegaly	1/76	0.0373647978046119	0.05800723590118368	0	0	29.503703703703703	96.97944863399397	APOE
Early-Stage Breast Carcinoma	1/76	0.0373647978046119	0.05800723590118368	0	0	29.503703703703703	96.97944863399397	APOE
Conventional (Clear Cell) Renal Cell Carcinoma	2/631	0.03781005183729045	0.05836972765782822	0	0	7.6951510333863276	25.20300699378214	KRT8;CTSD
Neoplastic Syndromes, Hereditary	1/77	0.037847950012518214	0.05836972765782822	0	0	29.114035087719298	95.32454660857232	PLAU
Niemann-Pick Disease, Type C	1/77	0.037847950012518214	0.05836972765782822	0	0	29.114035087719298	95.32454660857232	APOE
High-Grade Prostatic Intraepithelial Neoplasia	1/77	0.037847950012518214	0.05836972765782822	0	0	29.114035087719298	95.32454660857232	CTSH
PANIC DISORDER 1	1/77	0.037847950012518214	0.05836972765782822	0	0	29.114035087719298	95.32454660857232	APOE
Triple Negative Breast Neoplasms	2/632	0.03791995191838678	0.058403720411849984	0	0	7.682539682539683	25.13940458527679	LGALS3;MFGE8
Cerebral arterial aneurysm	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	APOE
Multiple Sclerosis, Relapsing-Remitting	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	APOE
Sudden infant death syndrome	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	APOE
Abnormal vision	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	CTSD
Peripheral Vascular Diseases	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	APOE
Dyskinetic syndrome	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	APOE
Pulmonary Edema	1/78	0.03833088396798601	0.05849713232190031	0	0	28.734487734487736	93.71751271850756	HSPA1A
Esophageal Neoplasms	2/637	0.03847138030526418	0.05863499814452911	0	0	7.6200787401574805	24.82500252596422	LGALS3;PLAU
Kidney Diseases	2/639	0.03869284901273761	0.05889575585402379	0	0	7.595368916797488	24.700902870114923	APOE;CTSD
Immunologic Deficiency Syndromes	2/641	0.038914828966672456	0.05915661256442146	0	0	7.570813771517997	24.57773760626809	PLAU;HSPA1A
Luminal B Breast Carcinoma	1/80	0.03929609749471	0.05965862074196881	0	0	28.0042194092827	90.63929849888726	KRT8
Sensory neuropathy	1/81	0.03977837723795202	0.06015643336502705	0	0	27.65277777777778	89.16449601956255	APOE
Vascular lesions	1/81	0.03977837723795202	0.06015643336502705	0	0	27.65277777777778	89.16449601956255	APOE
Acute myelomonocytic leukemia	1/81	0.03977837723795202	0.06015643336502705	0	0	27.65277777777778	89.16449601956255	PLAU
Malignant neoplasm of tongue	1/82	0.04026043907859986	0.06049415589059541	0	0	27.310013717421125	87.73030443537515	LGALS3
Hyperlipidemia, Familial Combined	1/82	0.04026043907859986	0.06049415589059541	0	0	27.310013717421125	87.73030443537515	APOE
Cholecystolithiasis	1/82	0.04026043907859986	0.06049415589059541	0	0	27.310013717421125	87.73030443537515	APOE
Thalassemia	1/82	0.04026043907859986	0.06049415589059541	0	0	27.310013717421125	87.73030443537515	APOE
Prediabetes syndrome	1/82	0.04026043907859986	0.06049415589059541	0	0	27.310013717421125	87.73030443537515	HSPA1A
Carcinoma, Neuroendocrine	1/83	0.040742283114183236	0.06113957504554584	0	0	26.975609756097562	86.33513767066536	PLAU
Situs Inversus	1/84	0.04122390942081947	0.0615462964405338	0	0	26.649263721552877	84.97748965941867	IFITM3
Sloping forehead	1/84	0.04122390942081947	0.0615462964405338	0	0	26.649263721552877	84.97748965941867	CTSD
Hemochromatosis	1/84	0.04122390942081947	0.0615462964405338	0	0	26.649263721552877	84.97748965941867	APOE
Thrombophilia	1/84	0.04122390942081947	0.0615462964405338	0	0	26.649263721552877	84.97748965941867	APOE
Cicatrix, Hypertrophic	1/85	0.041705318095063774	0.061869945245088265	0	0	26.33068783068783	83.65592938917332	PLAU
Increased tendency to bruise	1/85	0.041705318095063774	0.061869945245088265	0	0	26.33068783068783	83.65592938917332	PLAU
Alcoholic Liver Diseases	1/85	0.041705318095063774	0.061869945245088265	0	0	26.33068783068783	83.65592938917332	KRT8
Prostatic Hyperplasia	1/85	0.041705318095063774	0.061869945245088265	0	0	26.33068783068783	83.65592938917332	EEF1A1
Lesion of brain	1/85	0.041705318095063774	0.061869945245088265	0	0	26.33068783068783	83.65592938917332	APOE
Leishmaniasis, Visceral	1/86	0.0421865092184754	0.062189192025722255	0	0	26.019607843137255	82.36909635390154	HSPA1A
Headache	1/86	0.0421865092184754	0.062189192025722255	0	0	26.019607843137255	82.36909635390154	APOE
Herpes NOS	1/86	0.0421865092184754	0.062189192025722255	0	0	26.019607843137255	82.36909635390154	APOE
Diabetic Neuropathies	1/86	0.0421865092184754	0.062189192025722255	0	0	26.019607843137255	82.36909635390154	APOE
Leukoencephalopathies	1/86	0.0421865092184754	0.062189192025722255	0	0	26.019607843137255	82.36909635390154	APOE
Multiple tumors	1/87	0.04266748288266354	0.06281900187636483	0	0	25.71576227390181	81.11569629500502	LGALS3
Chordoma	1/88	0.0431482391729825	0.06336720049399062	0	0	25.41890166028097	79.89449726957503	PLAU
Iron Overload	1/88	0.0431482391729825	0.06336720049399062	0	0	25.41890166028097	79.89449726957503	APOE
Retinal Degeneration	1/89	0.043628778176876784	0.06359356819048499	0	0	25.12878787878788	78.70432597937861	CTSD
Cerebral Palsy	1/89	0.043628778176876784	0.06359356819048499	0	0	25.12878787878788	78.70432597937861	APOE
Chagas Disease	1/89	0.043628778176876784	0.06359356819048499	0	0	25.12878787878788	78.70432597937861	KRT8
Osteoarthrosis Deformans	1/89	0.043628778176876784	0.06359356819048499	0	0	25.12878787878788	78.70432597937861	CTSD
Hypotension	1/89	0.043628778176876784	0.06359356819048499	0	0	25.12878787878788	78.70432597937861	PLAU
Acute Kidney Insufficiency	1/89	0.043628778176876784	0.06359356819048499	0	0	25.12878787878788	78.70432597937861	HSPA1A
Secondary malignant neoplasm of lung	2/683	0.04369271888723341	0.06360745750831365	0	0	7.088472834067548	22.19098738323626	PLAU;CTSD
Motor neuron atrophy	1/90	0.04410909997700312	0.0639746127458023	0	0	24.845193508114857	77.54406436315156	EEF1A1
Venous Thrombosis	1/90	0.04410909997700312	0.0639746127458023	0	0	24.845193508114857	77.54406436315156	PLAU
Adenovirus Infections	1/90	0.04410909997700312	0.0639746127458023	0	0	24.845193508114857	77.54406436315156	PLAU
Prolactinoma	1/91	0.0445892046624482	0.06459080576257986	0	0	24.567901234567902	76.41264641223972	LGALS3
Diabetes Mellitus, Non-Insulin-Dependent	3/1672	0.04480415929746236	0.06482185918160087	0	0	4.704527946589061	14.609696552540663	CTSH;APOE;HSPA1A
Thyroid associated opthalmopathies	1/92	0.04506909232552398	0.06496395675528673	0	0	24.296703296703296	75.30905521028181	HSPA1A
Acute kidney injury	1/92	0.04506909232552398	0.06496395675528673	0	0	24.296703296703296	75.30905521028181	HSPA1A
Premature aging syndrome	1/92	0.04506909232552398	0.06496395675528673	0	0	24.296703296703296	75.30905521028181	APOE
Mucinous Adenocarcinoma	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	LGALS3
Osteoarthritis, Knee	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	PLAU
PARKINSON DISEASE, LATE-ONSET	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	APOE
Subarachnoid Hemorrhage	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	APOE
Panic Disorder	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	APOE
Intraepithelial Neoplasia	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	PLAU
Edema	1/93	0.04554876304685277	0.06509352567453654	0	0	24.031400966183575	74.2323201774775	APOE
Pancreatic Ductal Adenocarcinoma	2/701	0.045806964902940076	0.06538259092983754	0	0	6.899499284692418	21.27335811333444	LGALS3;PLAU
AMYOTROPHIC LATERAL SCLEROSIS 1	1/94	0.04602821692612118	0.06561827510565324	0	0	23.77180406212664	73.18151447362185	CTSD
Membranous glomerulonephritis	1/95	0.046507454029938514	0.06605979800850319	0	0	23.5177304964539	72.15575261450543	APOE
Gastric ulcer	1/95	0.046507454029938514	0.06605979800850319	0	0	23.5177304964539	72.15575261450543	PLAU
Limb ischemia	1/95	0.046507454029938514	0.06605979800850319	0	0	23.5177304964539	72.15575261450543	PLAU
Leukemia, Myelocytic, Acute	3/1703	0.0469468707220076	0.06649780708028859	0	0	4.610924369747899	14.103612936267169	LGALS3;PLAU;CTSH
Renal failure in adulthood	1/96	0.04698647446391648	0.06649780708028859	0	0	23.269005847953217	71.15418818005004	APOE
Cardiac fibrosis	1/96	0.04698647446391648	0.06649780708028859	0	0	23.269005847953217	71.15418818005004	PLAU
Ovarian Serous Adenocarcinoma	1/97	0.047465278302624564	0.06701317673401946	0	0	23.025462962962962	70.17601174086535	KRT8
Adult Hepatocellular Carcinoma	1/97	0.047465278302624564	0.06701317673401946	0	0	23.025462962962962	70.17601174086535	PLAU
Frontotemporal Lobar Degeneration	1/98	0.04794386563583509	0.06736343621188848	0	0	22.786941580756015	69.220448859451	APOE
Mycobacterium Infections	1/98	0.04794386563583509	0.06736343621188848	0	0	22.786941580756015	69.220448859451	LGALS3
Henoch-Schoenlein Purpura	1/98	0.04794386563583509	0.06736343621188848	0	0	22.786941580756015	69.220448859451	PLAU
Thrombosis	1/98	0.04794386563583509	0.06736343621188848	0	0	22.786941580756015	69.220448859451	PLAU
Atonic Absence Seizures	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Generalized Absence Seizures	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Single Seizure	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Sleep disturbances	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Gustatory seizure	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Neuromuscular Diseases	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Non-epileptic convulsion	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Nonepileptic Seizures	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Olfactory seizure	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Seizures, Auditory	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Seizures, Clonic	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Seizures, Sensory	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Seizures, Somatosensory	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Vertiginous seizure	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Jacksonian Seizure	1/101	0.04937832948591827	0.06815025639792026	0	0	22.1	66.48218412151981	APOE
Intervertebral Disc Degeneration	1/102	0.049856051675230315	0.06856673459805204	0	0	21.88008800880088	65.60996868685889	LGALS3
Adult Acute Myeloblastic Leukemia	1/102	0.049856051675230315	0.06856673459805204	0	0	21.88008800880088	65.60996868685889	LGALS3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	1/102	0.049856051675230315	0.06856673459805204	0	0	21.88008800880088	65.60996868685889	LGALS3
Epileptic Seizures	1/103	0.050333557792203866	0.06914210230209909	0	0	21.664488017429193	64.75695871628933	APOE
Carcinoid tumor no ICD-O subtype	1/104	0.050810847928028736	0.06963409288143681	0	0	21.45307443365696	63.922554665894864	PLAU
Tonic Seizures	1/104	0.050810847928028736	0.06963409288143681	0	0	21.45307443365696	63.922554665894864	APOE
Biliary Atresia	1/105	0.051287922166042506	0.07012348656386397	0	0	21.245726495726494	63.10618119534448	PLAU
Pick Disease of the Brain	1/105	0.051287922166042506	0.07012348656386397	0	0	21.245726495726494	63.10618119534448	APOE
Endometriosis	2/749	0.051633236385825274	0.07051314641942728	0	0	6.440093708165997	19.08579536667028	PLAU;APOE
Malignant Testicular Germ Cell Tumor	1/106	0.05176478059643375	0.07052800526483807	0	0	21.04232804232804	62.30728596638391	APOE
Teratocarcinoma	1/106	0.05176478059643375	0.07052800526483807	0	0	21.04232804232804	62.30728596638391	APOE
Alcohol abuse	1/107	0.05224142330784828	0.07109455628274114	0	0	20.842767295597483	61.52533852087739	APOE
Red cell distribution width determination	1/108	0.052717850378226405	0.07149323328555297	0	0	20.64693665628245	60.75982922373895	APOE
Tumor Promotion	1/108	0.052717850378226405	0.07149323328555297	0	0	20.64693665628245	60.75982922373895	CTSD
RDW - Red blood cell distribution width result	1/108	0.052717850378226405	0.07149323328555297	0	0	20.64693665628245	60.75982922373895	APOE
Coronary Arteriosclerosis	2/760	0.053005988040602754	0.07180069527168553	0	0	6.3430079155672825	18.631636774018027	APOE;HSPA1A
Convulsive Seizures	1/109	0.053194061897419175	0.07197205828481831	0	0	20.454732510288064	60.01026825392258	APOE
Weight Gain	1/110	0.05367005795312965	0.07228144901752138	0	0	20.26605504587156	59.276184666906936	CTSD
Deep Vein Thrombosis	1/110	0.05367005795312965	0.07228144901752138	0	0	20.26605504587156	59.276184666906936	PLAU
Polymicrogyria	1/110	0.05367005795312965	0.07228144901752138	0	0	20.26605504587156	59.276184666906936	EEF1A1
Luminal A Breast Carcinoma	1/110	0.05367005795312965	0.07228144901752138	0	0	20.26605504587156	59.276184666906936	KRT8
Glomerulosclerosis (disorder)	1/112	0.05462140403176767	0.07330932412530013	0	0	19.8988988988989	57.85265494685789	APOE
Synovitis	1/112	0.05462140403176767	0.07330932412530013	0	0	19.8988988988989	57.85265494685789	PLAU
Infectious disease of lung	1/112	0.05462140403176767	0.07330932412530013	0	0	19.8988988988989	57.85265494685789	LGALS3
Diabetes Mellitus, Experimental	1/113	0.055096754219821284	0.07360926363768124	0	0	19.720238095238095	57.16235353894127	MFGE8
Streptozotocin Diabetes	1/113	0.055096754219821284	0.07360926363768124	0	0	19.720238095238095	57.16235353894127	MFGE8
Alloxan Diabetes	1/113	0.055096754219821284	0.07360926363768124	0	0	19.720238095238095	57.16235353894127	MFGE8
Lipodystrophy	1/113	0.055096754219821284	0.07360926363768124	0	0	19.720238095238095	57.16235353894127	APOE
Urticaria	1/114	0.055571889296304126	0.07407473043030732	0	0	19.54473942969518	56.48581741086853	CTSD
Intracranial Aneurysm	1/114	0.055571889296304126	0.07407473043030732	0	0	19.54473942969518	56.48581741086853	APOE
Nasopharyngeal carcinoma	2/782	0.055792344242994854	0.07428388430530863	0	0	6.157051282051282	17.76998034298264	CTSD;HSPA1A
Epileptic drop attack	1/115	0.056046809334145735	0.07445309103592769	0	0	19.37231968810916	55.822657592283626	APOE
Pancreatic intraepithelial neoplasia	1/115	0.056046809334145735	0.07445309103592769	0	0	19.37231968810916	55.822657592283626	PLAU
Acute Myeloid Leukemia, M1	1/116	0.05652151443253849	0.07457522615308973	0	0	19.202898550724637	55.17249932078826	CTSH
Experimental Hepatoma	1/116	0.05652151443253849	0.07457522615308973	0	0	19.202898550724637	55.17249932078826	MFGE8
Condition, Preneoplastic	1/116	0.05652151443253849	0.07457522615308973	0	0	19.202898550724637	55.17249932078826	KRT8
Liver Neoplasms, Experimental	1/116	0.05652151443253849	0.07457522615308973	0	0	19.202898550724637	55.17249932078826	MFGE8
Complex partial seizures	1/116	0.05652151443253849	0.07457522615308973	0	0	19.202898550724637	55.17249932078826	APOE
Ischemic cardiomyopathy	1/116	0.05652151443253849	0.07457522615308973	0	0	19.202898550724637	55.17249932078826	APOE
Carcinoma, Small Cell	1/117	0.05699600466701817	0.07503190254025252	0	0	19.03639846743295	54.53498142318387	LGALS3
Hyperhomocysteinemia	1/117	0.05699600466701817	0.07503190254025252	0	0	19.03639846743295	54.53498142318387	APOE
Convulsions	1/118	0.057470280137791985	0.07557115577174223	0	0	18.872744539411205	53.909755696325554	APOE
Hepatoma, Novikoff	1/119	0.05794434091963676	0.07593826741598136	0	0	18.71186440677966	53.29648635296648	MFGE8
Giant Cell Arteritis	1/119	0.05794434091963676	0.07593826741598136	0	0	18.71186440677966	53.29648635296648	MFGE8
Von Hippel-Lindau Syndrome	1/119	0.05794434091963676	0.07593826741598136	0	0	18.71186440677966	53.29648635296648	PLAU
Liver Failure, Acute	1/120	0.05841818710428844	0.0764735282473832	0	0	18.553688141923438	52.69484946624011	KRT8
Malignant neoplasm of liver	2/805	0.05876245950038024	0.07675116771927662	0	0	5.973536737235367	16.930508873725966	PLAU;KRT8
Hepatoma, Morris	1/121	0.058891818780966686	0.07675116771927662	0	0	18.39814814814815	52.104532462734575	MFGE8
Acute Myeloid Leukemia (AML-M2)	1/121	0.058891818780966686	0.07675116771927662	0	0	18.39814814814815	52.104532462734575	CTSH
HIV Infections	2/806	0.05889289772813612	0.07675116771927662	0	0	5.965796019900497	16.895341803593254	APOE;CTSD
Pilocytic Astrocytoma	1/122	0.0593652360295357	0.07728058008744682	0	0	18.245179063360883	51.52523363729626	LGALS3
Hyperplasia	1/123	0.059838438928516126	0.07772348345270595	0	0	18.094717668488162	50.95666168783963	PLAU
Absence Seizures	1/123	0.059838438928516126	0.07772348345270595	0	0	18.094717668488162	50.95666168783963	APOE
Heart failure	2/815	0.060071670078208766	0.07793982499603336	0	0	5.896986469864698	16.58360517654276	LGALS3;APOE
CNS disorder	1/124	0.060311427588576154	0.07816414506767796	0	0	17.946702800361336	50.39853526607874	APOE
Psoriasis	2/818	0.060466516535968996	0.07825631302358518	0	0	5.8743872549019605	16.481565730141735	PLAU;APOE
Familial M??ni??re disease	1/125	0.06078420207477788	0.07825631302358518	0	0	17.801075268817204	49.85058258369441	HSPA1A
Myotonic Dystrophy	1/125	0.06078420207477788	0.07825631302358518	0	0	17.801075268817204	49.85058258369441	APOE
Tetralogy of Fallot	1/125	0.06078420207477788	0.07825631302358518	0	0	17.801075268817204	49.85058258369441	APOE
Congenital hypoplasia of lung	1/125	0.06078420207477788	0.07825631302358518	0	0	17.801075268817204	49.85058258369441	APOE
Peripheral Arterial Diseases	1/125	0.06078420207477788	0.07825631302358518	0	0	17.801075268817204	49.85058258369441	APOE
Memory Loss	1/126	0.06125676247542812	0.07851881067299943	0	0	17.657777777777778	49.3125409946923	APOE
Generalized seizures	1/126	0.06125676247542812	0.07851881067299943	0	0	17.657777777777778	49.3125409946923	APOE
Myocarditis	1/126	0.06125676247542812	0.07851881067299943	0	0	17.657777777777778	49.3125409946923	LGALS3
Left-Sided Heart Failure	1/126	0.06125676247542812	0.07851881067299943	0	0	17.657777777777778	49.3125409946923	APOE
beta^+^ Thalassemia	1/128	0.062201241380010173	0.07955497940178544	0	0	17.37795275590551	48.26518401321974	APOE
Peritonitis	1/128	0.062201241380010173	0.07955497940178544	0	0	17.37795275590551	48.26518401321974	APOE
Hepatitis, Autoimmune	1/129	0.06267316005242175	0.07963578706660981	0	0	17.241319444444443	47.75538577401706	KRT8
Chronic liver disease	1/129	0.06267316005242175	0.07963578706660981	0	0	17.241319444444443	47.75538577401706	APOE
Seizures, Focal	1/129	0.06267316005242175	0.07963578706660981	0	0	17.241319444444443	47.75538577401706	APOE
tumor vasculature	1/129	0.06267316005242175	0.07963578706660981	0	0	17.241319444444443	47.75538577401706	PLAU
Pervasive Development Disorder	1/129	0.06267316005242175	0.07963578706660981	0	0	17.241319444444443	47.75538577401706	APOE
Endometrial adenocarcinoma	1/129	0.06267316005242175	0.07963578706660981	0	0	17.241319444444443	47.75538577401706	CTSD
Bipolar Disorder	2/837	0.06298928441619066	0.07995056838493689	0	0	5.735029940119761	15.856157188540967	APOE;MFGE8
Neoplastic Cell Transformation	1/131	0.06361635628304867	0.08048432953991763	0	0	16.974358974358974	46.76240127804881	LGALS3
Disorder of eye	1/131	0.06361635628304867	0.08048432953991763	0	0	16.974358974358974	46.76240127804881	APOE
Pseudohyperkalemia Cardiff	1/131	0.06361635628304867	0.08048432953991763	0	0	16.974358974358974	46.76240127804881	APOE
Autoimmune thyroid disease	1/132	0.06408763400637407	0.08090544724994739	0	0	16.843935538592028	46.27877775631816	HSPA1A
Mouth Neoplasms	1/132	0.06408763400637407	0.08090544724994739	0	0	16.843935538592028	46.27877775631816	PLAU
beta Thalassemia	1/133	0.06455869825192352	0.08132448087984763	0	0	16.715488215488215	45.803453495550436	APOE
Lewy Body Disease	1/133	0.06455869825192352	0.08132448087984763	0	0	16.715488215488215	45.803453495550436	APOE
Thyroid Gland Follicular Adenoma	1/134	0.06502954909759474	0.08174144397321319	0	0	16.588972431077693	45.33622688859099	LGALS3
Tumor Immunity	1/134	0.06502954909759474	0.08174144397321319	0	0	16.588972431077693	45.33622688859099	HSPA1A
leukemia	3/1941	0.06515620962886735	0.08181268427083345	0	0	3.9920389208314906	10.902129218811416	LGALS3;APOE;HSPA1A
Motor Neuron Disease	1/135	0.06550018663706729	0.08198042631555852	0	0	16.46434494195688	44.87690266099937	APOE
Mycoses	1/135	0.06550018663706729	0.08198042631555852	0	0	16.46434494195688	44.87690266099937	CTSD
Dystonia Disorders	1/135	0.06550018663706729	0.08198042631555852	0	0	16.46434494195688	44.87690266099937	APOE
Follicular adenoma	1/136	0.06597061096485848	0.0823927822841021	0	0	16.34156378600823	44.425291631018546	LGALS3
Cholelithiasis	1/136	0.06597061096485848	0.0823927822841021	0	0	16.34156378600823	44.425291631018546	APOE
Lymphopenia	1/137	0.06644082214506918	0.08289148461855482	0	0	16.220588235294116	43.98121048429159	CTSD
Measles	1/138	0.06691082028574227	0.08330005209162163	0	0	16.101378751013787	43.544481533030364	HSPA1A
Psoriasis vulgaris	1/138	0.06691082028574227	0.08330005209162163	0	0	16.101378751013787	43.544481533030364	APOE
Differentiated Thyroid Gland Carcinoma	1/139	0.0673806054536277	0.08379566784605402	0	0	15.98389694041868	43.114932524579174	LGALS3
Cholangitis, Sclerosing	1/140	0.06785017773889719	0.08420048596260173	0	0	15.86810551558753	42.692396422608226	PLAU
Thyroid Diseases	1/140	0.06785017773889719	0.08420048596260173	0	0	15.86810551558753	42.692396422608226	LGALS3
Lymphatic Metastasis	1/142	0.06878868402799701	0.08518429197958528	0	0	15.641449960598896	41.86771974668722	PLAU
Vascular inflammations	1/142	0.06878868402799701	0.08518429197958528	0	0	15.641449960598896	41.86771974668722	APOE
Myositis	1/143	0.06925761819784873	0.08549330060536976	0	0	15.530516431924882	41.46526951018726	APOE
Supratentorial atrophy	1/143	0.06925761819784873	0.08549330060536976	0	0	15.530516431924882	41.46526951018726	CTSD
Leprosy	1/143	0.06925761819784873	0.08549330060536976	0	0	15.530516431924882	41.46526951018726	LGALS3
Malignant tumor of cervix	2/884	0.06938959230729856	0.08556585802450635	0	0	5.416099773242631	14.450253794210974	LGALS3;PLAU
Disease Exacerbation	1/144	0.06972633982778743	0.08580009606177212	0	0	15.421134421134422	41.069212505400955	APOE
Encephalitis	1/144	0.06972633982778743	0.08580009606177212	0	0	15.421134421134422	41.069212505400955	APOE
Mammary Carcinoma, Animal	1/145	0.07019484901226249	0.086104699365514	0	0	15.313271604938272	40.67940505968954	EEF1A1
Nerve Degeneration	1/145	0.07019484901226249	0.086104699365514	0	0	15.313271604938272	40.67940505968954	APOE
Animal Mammary Neoplasms	1/145	0.07019484901226249	0.086104699365514	0	0	15.313271604938272	40.67940505968954	EEF1A1
Glaucoma, Primary Open Angle	1/147	0.07113123037086004	0.08707058461103181	0	0	15.101978691019786	39.91798490572592	APOE
Depressive Symptoms	1/147	0.07113123037086004	0.08707058461103181	0	0	15.101978691019786	39.91798490572592	APOE
Mild cognitive disorder	1/150	0.07253421117312703	0.0886950762148384	0	0	14.795674869500372	38.81936703082998	APOE
Primary Sj??gren's syndrome	1/151	0.07300144744630711	0.08908005434732047	0	0	14.696296296296296	38.464263732129254	APOE
Pulmonary Hypertension	1/151	0.07300144744630711	0.08908005434732047	0	0	14.696296296296296	38.464263732129254	APOE
Familial lichen amyloidosis	1/153	0.07393528453317921	0.08993792676304527	0	0	14.501461988304094	37.77000181895698	APOE
Hyperlipoproteinemia Type IIa	1/153	0.07393528453317921	0.08993792676304527	0	0	14.501461988304094	37.77000181895698	APOE
Primary Effusion Lymphoma	1/153	0.07393528453317921	0.08993792676304527	0	0	14.501461988304094	37.77000181895698	CTSD
Hypercholesterolemia, Familial	1/154	0.07440188549950799	0.09022386322502576	0	0	14.405954974582425	37.43061817969281	APOE
Myoclonus	1/154	0.07440188549950799	0.09022386322502576	0	0	14.405954974582425	37.43061817969281	APOE
Invasive Carcinoma	1/154	0.07440188549950799	0.09022386322502576	0	0	14.405954974582425	37.43061817969281	PLAU
Abnormality of metabolism/homeostasis	1/155	0.0748682748782873	0.0906953506038527	0	0	14.311688311688311	37.09625453392642	CTSD
Myoclonic Seizures	1/156	0.07533445276005073	0.09116560587629327	0	0	14.21863799283154	36.76680591747282	APOE
Hypertriglyceridemia	1/157	0.07580041919374052	0.09163463292397381	0	0	14.126780626780628	36.44217021371992	APOE
Mammary Neoplasms, Experimental	1/160	0.07719705081553525	0.09322660372248007	0	0	13.858141160027952	35.496159958699565	EEF1A1
Polycystic Kidney, Autosomal Dominant	1/161	0.07766217240578246	0.09369151655558276	0	0	13.770833333333334	35.189808228245795	APOE
Malignant neoplasm of brain	1/166	0.07998461707111014	0.0961597812113483	0	0	13.35016835016835	33.721469913824805	PLAU
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	1/166	0.07998461707111014	0.0961597812113483	0	0	13.35016835016835	33.721469913824805	HSPA1A
Follicular thyroid carcinoma	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	LGALS3
Hereditary hemochromatosis	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	APOE
Transitional cell carcinoma of bladder	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	HSPA1A
Infratentorial atrophy	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	CTSD
Degenerative brain disorder	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	CTSD
Irritable Bowel Syndrome	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	KRT8
Progressive Neoplastic Disease	1/167	0.08044847393045221	0.0961597812113483	0	0	13.269076305220883	33.439908396149875	APOE
cervical cancer	2/965	0.0809258554557584	0.09663158838384225	0	0	4.939511941848391	12.419029140285206	LGALS3;PLAU
Progressive cGVHD	1/169	0.08137555627963242	0.09706941356213296	0	0	13.109788359788359	32.88826835221049	APOE
Tonic - clonic seizures	1/173	0.0832271978105011	0.09913446109146583	0	0	12.80232558139535	31.82889974049287	APOE
Coronary Artery Disease	2/981	0.08327633942841697	0.09913446109146583	0	0	4.854698672114402	12.066794407793292	APOE;HSPA1A
Carcinomatosis	1/176	0.08461372384354178	0.1004197392620308	0	0	12.58095238095238	31.07065982483502	EEF1A1
Well Differentiated Oligodendroglioma	1/176	0.08461372384354178	0.1004197392620308	0	0	12.58095238095238	31.07065982483502	LGALS3
Anaplastic thyroid carcinoma	1/176	0.08461372384354178	0.1004197392620308	0	0	12.58095238095238	31.07065982483502	LGALS3
Refractory cancer	1/177	0.08507547962611925	0.10086535059121034	0	0	12.508838383838384	30.82448495215476	CTSD
Scleroderma	1/179	0.0859983623481033	0.10185621639810817	0	0	12.367041198501873	30.34163310031636	PLAU
Nephrotic Syndrome	1/182	0.08738111558780785	0.10338919445561476	0	0	12.160220994475138	29.64024790437689	APOE
oligodendroglioma	1/183	0.0878416147770708	0.10382896630373686	0	0	12.092796092796092	29.41233952395038	LGALS3
Proteinuria	1/184	0.08830190483291274	0.10426760277744948	0	0	12.026108075288404	29.18728732343428	APOE
Respiratory Failure	1/185	0.08876198582918055	0.104599557897492	0	0	11.960144927536232	28.96504081050499	CTSD
Malignant neoplasm of testis	1/185	0.08876198582918055	0.104599557897492	0	0	11.960144927536232	28.96504081050499	APOE
Hashimoto Disease	1/186	0.08922185787739563	0.10492993144735965	0	0	11.894894894894895	28.745550642557202	LGALS3
Respiratory Distress Syndrome, Adult	1/186	0.08922185787739563	0.10492993144735965	0	0	11.894894894894895	28.745550642557202	HSPA1A
Carcinoma, Spindle-Cell	1/188	0.09014097538434816	0.1057979921930753	0	0	11.766488413547236	28.314647577691105	EEF1A1
Acquired Immunodeficiency Syndrome	1/188	0.09014097538434816	0.1057979921930753	0	0	11.766488413547236	28.314647577691105	APOE
Cerebellar atrophy	1/190	0.091059258031028	0.10655482746573747	0	0	11.640799529688419	27.89420530874704	CTSD
Muscular Dystrophy, Duchenne	1/190	0.091059258031028	0.10655482746573747	0	0	11.640799529688419	27.89420530874704	PLAU
Dermatitis	1/190	0.091059258031028	0.10655482746573747	0	0	11.640799529688419	27.89420530874704	PLAU
Platelet Count measurement	1/191	0.09151808650896284	0.10698464312897757	0	0	11.578947368421053	27.68779500438416	APOE
Cerebellar degeneration	1/193	0.09243511814112873	0.10784860171827305	0	0	11.457175925925926	27.282380766060548	CTSD
Osteosarcoma of bone	2/1042	0.09244165861566261	0.10784860171827305	0	0	4.555288461538462	10.84695062348375	LGALS3;PLAU
Eclampsia	1/194	0.09289332148048067	0.10826749033966292	0	0	11.397236614853195	27.083293544100204	APOE
Carcinoma, Papillary	1/196	0.0938091036064344	0.10911725583673812	0	0	11.279202279202279	26.69215746118742	LGALS3
Spinal Muscular Atrophy	1/196	0.0938091036064344	0.10911725583673812	0	0	11.279202279202279	26.69215746118742	APOE
Aplasia Cutis Congenita	1/199	0.09518121669844049	0.11060322298258143	0	0	11.10662177328844	26.122470758395618	CTSH
Reticulocyte count (procedure)	1/202	0.0965514597102952	0.11208406792585413	0	0	10.939192924267552	25.572323233557647	APOE
Malignant neoplasm of gallbladder	1/203	0.09700779219633389	0.1125020923388039	0	0	10.884488448844884	25.39311940245665	APOE
Papilloma	1/204	0.09746391722029348	0.11280724676289412	0	0	10.83032293377121	25.21594900155374	APOE
Leukodystrophy	1/204	0.09746391722029348	0.11280724676289412	0	0	10.83032293377121	25.21594900155374	EEF1A1
Visual seizure	1/207	0.0988310484246783	0.11416353320992978	0	0	10.670981661272924	24.696316707963092	APOE
Liver Dysfunction	1/207	0.0988310484246783	0.11416353320992978	0	0	10.670981661272924	24.696316707963092	HSPA1A
Myxoid cyst	1/209	0.0997414334930266	0.115101417328083	0	0	10.567307692307692	24.359484069513947	APOE
Germ cell tumor	1/210	0.10019631555317604	0.11551232039611715	0	0	10.516214779372675	24.193854658645943	EEF1A1
Congenital contractural arachnodactyly	1/212	0.10110545917546415	0.11644559780898286	0	0	10.415481832543444	23.86802605954351	LGALS3
Carcinoid Tumor	1/213	0.10155972088956865	0.1168536552361277	0	0	10.365828092243186	23.707771159120533	PLAU
Parkinsonian Disorders	1/214	0.10201377599043508	0.1171454853956961	0	0	10.316640584246217	23.549252972335328	APOE
Craniosynostosis	1/214	0.10201377599043508	0.1171454853956961	0	0	10.316640584246217	23.549252972335328	CTSD
Cervix carcinoma	2/1105	0.10222848849565155	0.11727684303377495	0	0	4.280825022665458	9.762613620377307	LGALS3;PLAU
Restenosis	1/215	0.10246762456232947	0.11743593442486583	0	0	10.26791277258567	23.39244500807539	APOE
Carcinoma	1/216	0.10292126667378525	0.11760993229878296	0	0	10.219638242894057	23.237321299310643	EEF1A1
Adenocarcinoma of prostate	1/216	0.10292126667378525	0.11760993229878296	0	0	10.219638242894057	23.237321299310643	CTSD
Dyslipidemias	1/216	0.10292126667378525	0.11760993229878296	0	0	10.219638242894057	23.237321299310643	APOE
Severe Combined Immunodeficiency	1/217	0.10337470241563904	0.11801272180066605	0	0	10.171810699588477	23.083856386639766	PLAU
Nonorganic psychosis	1/220	0.10473377232824393	0.11944759009923624	0	0	10.030948756976155	22.633167224683852	APOE
Severe mental retardation (I.Q. 20-34)	1/224	0.10654298144758934	0.1213925392906744	0	0	9.849028400597907	22.054011304804124	CTSD
Malnutrition	1/225	0.1069947692716383	0.12155188073716731	0	0	9.804563492063492	21.912957536249337	APOE
Gastrointestinal Carcinoid Tumor	1/225	0.1069947692716383	0.12155188073716731	0	0	9.804563492063492	21.912957536249337	KRT8
Pulmonary Emphysema	1/225	0.1069947692716383	0.12155188073716731	0	0	9.804563492063492	21.912957536249337	KRT8
Tremor	1/226	0.10744635148098797	0.121828113366901	0	0	9.760493827160493	21.773354464537373	APOE
Ventricular Septal Defects	1/226	0.10744635148098797	0.121828113366901	0	0	9.760493827160493	21.773354464537373	APOE
Ki-1+ Anaplastic Large Cell Lymphoma	1/228	0.10834889939046503	0.12273242576303646	0	0	9.673519334312285	21.498416879687177	HSPA1A
Anemia, Sickle Cell	1/231	0.10970118119988245	0.1241439310964788	0	0	9.545893719806763	21.096378767938067	MFGE8
Metastasis from malignant tumor of prostate	1/232	0.11015153146412886	0.12429260644938864	0	0	9.504088504088504	20.96505269691893	EEF1A1
Hyperlipidemia	1/232	0.11015153146412886	0.12429260644938864	0	0	9.504088504088504	20.96505269691893	APOE
Hypoglycemia	1/232	0.11015153146412886	0.12429260644938864	0	0	9.504088504088504	20.96505269691893	APOE
Epstein-Barr Virus Infections	1/234	0.11105161697319653	0.12518740621182906	0	0	9.421554601812112	20.706317424316197	CTSH
Microcephaly	1/235	0.11150135236226262	0.12545243591095764	0	0	9.380816714150047	20.578871727653997	CTSD
Hepatoblastoma	1/235	0.11150135236226262	0.12545243591095764	0	0	9.380816714150047	20.578871727653997	APOE
Cognition Disorders	1/237	0.11240020889319374	0.12622079173500816	0	0	9.300376647834275	20.327735427518473	APOE
Undifferentiated carcinoma	1/237	0.11240020889319374	0.12622079173500816	0	0	9.300376647834275	20.327735427518473	EEF1A1
Hepatitis B, Chronic	1/238	0.1128493302031557	0.12648213519414095	0	0	9.26066572902016	20.20401026619315	LGALS3
Endometrial Neoplasms	1/238	0.1128493302031557	0.12648213519414095	0	0	9.26066572902016	20.20401026619315	PLAU
Seizures	2/1174	0.11329294174666406	0.1268577096761018	0	0	4.014078498293515	8.741773489296786	APOE;CTSD
Epilepsy	2/1177	0.11378173747000937	0.12728311110281432	0	0	4.003191489361702	8.700829614121117	APOE;CTSD
Metastatic Prostate Carcinoma	1/241	0.11419546719841087	0.12738024919364724	0	0	9.143518518518519	19.840005818533104	EEF1A1
Meningioma, benign, no ICD-O subtype	1/241	0.11419546719841087	0.12738024919364724	0	0	9.143518518518519	19.840005818533104	PLAU
Chondrosarcoma	1/241	0.11419546719841087	0.12738024919364724	0	0	9.143518518518519	19.840005818533104	PLAU
Splenomegaly	1/247	0.11688222762941927	0.1302529305040907	0	0	8.917795844625113	19.142837582768422	APOE
Immune System Diseases	1/250	0.11822285551261046	0.13162144580403964	0	0	8.80901383311022	18.808863891633447	HSPA1A
Patent ductus arteriosus	1/251	0.11866932428419916	0.13186733848690954	0	0	8.773333333333333	18.699609365844342	LGALS3
Dystonia	1/251	0.11866932428419916	0.13186733848690954	0	0	8.773333333333333	18.699609365844342	APOE
Acute Coronary Syndrome	1/255	0.12045316552223109	0.13372246010967537	0	0	8.6334208223972	18.272585696506454	APOE
Urothelial Carcinoma	1/257	0.12134386702270725	0.13458347300715823	0	0	8.565104166666666	18.06489149353045	HSPA1A
Narcolepsy	1/258	0.12178891326034945	0.13494904227615973	0	0	8.53134457414613	17.962455525511107	CTSH
Malignant Pleural Mesothelioma	1/260	0.1226783971960487	0.1356774326605307	0	0	8.464607464607464	17.760346311661674	PLAU
Sjogren's Syndrome	1/260	0.1226783971960487	0.1356774326605307	0	0	8.464607464607464	17.760346311661674	CTSD
Endothelial dysfunction	1/262	0.12356707023434739	0.1365311012324689	0	0	8.398893146019583	17.561843608876003	APOE
Male infertility	1/263	0.12401110286970286	0.1367631879761157	0	0	8.366412213740459	17.463916482539084	HSPA1A
Malignant neoplasm of gastrointestinal tract	1/263	0.12401110286970286	0.1367631879761157	0	0	8.366412213740459	17.463916482539084	PLAU
Refractory anemias	1/266	0.1253419862578444	0.13810064272895392	0	0	8.270440251572326	17.175300907975267	APOE
Memory impairment	1/267	0.12578520948987149	0.138458483892335	0	0	8.238930659983291	17.080782255368987	APOE
Hypothyroidism	1/268	0.12622823055296903	0.13881542946041467	0	0	8.207657095297545	16.98708959891292	APOE
Cytomegalovirus Infections	1/270	0.12711366660162637	0.13965777843731317	0	0	8.14580751755473	16.802141955832525	APOE
Bacterial Infections	1/276	0.12976513169934814	0.1423034136552889	0	0	7.965656565656565	16.266102840447306	CTSD
Rectal Carcinoma	1/276	0.12976513169934814	0.1423034136552889	0	0	7.965656565656565	16.266102840447306	APOE
Congenital Heart Defects	1/277	0.13020633712783028	0.1426534283996566	0	0	7.936392914653784	16.179407402399576	APOE
Pheochromocytoma	1/280	0.13152874576436102	0.1439673256540618	0	0	7.849860613301473	15.923676590358793	LGALS3
Anaplasia	1/283	0.13284934463064907	0.14514101296563436	0	0	7.765169424743893	15.674301518188736	KRT8
Low density lipoprotein cholesterol measurement	1/283	0.13284934463064907	0.14514101296563436	0	0	7.765169424743893	15.674301518188736	APOE
Lupus Vulgaris	1/284	0.13328914247909435	0.14534982048326614	0	0	7.737338044758539	15.59255061922831	MFGE8
Neuropathy	1/284	0.13328914247909435	0.14534982048326614	0	0	7.737338044758539	15.59255061922831	APOE
Anoxia	1/288	0.13504632704917388	0.14712875705543732	0	0	7.627951993805652	15.272207942328459	APOE
Migraine Disorders	1/290	0.13592371639621098	0.147938670689802	0	0	7.57439446366782	15.115927109932192	APOE
Hypertensive disease	2/1310	0.13604283232808992	0.147938670689802	0	0	3.5707186544342506	7.1228177937366	LGALS3;APOE
Multiple Myeloma	2/1312	0.13638586145480236	0.14817385877385125	0	0	3.564885496183206	7.102204424300888	LGALS3;HSPA1A
Low set ears	1/293	0.137238298617427	0.14896153303971416	0	0	7.495433789954338	14.886204776888695	CTSD
hearing impairment	1/294	0.13767609254055066	0.1491597332529228	0	0	7.469472885855138	14.810855577292921	APOE
Pituitary Adenoma	1/294	0.13767609254055066	0.1491597332529228	0	0	7.469472885855138	14.810855577292921	LGALS3
Pituitary Neoplasms	1/296	0.13855108060761448	0.14996871595398273	0	0	7.418079096045198	14.66195356777133	LGALS3
Idiopathic pulmonary arterial hypertension	1/297	0.1389882749155145	0.15030276908069976	0	0	7.392642642642643	14.58838744208992	LGALS3
Epithelial ovarian cancer	2/1329	0.13931080435504425	0.15051232004717813	0	0	3.5160135644310473	6.930230939580733	PLAU;KRT8
Adenocarcinoma Of Esophagus	1/299	0.13986206452524058	0.15096837805171395	0	0	7.342281879194631	14.442992371926008	CTSD
Choriocarcinoma	1/300	0.1402986599880225	0.1512999386771202	0	0	7.3173541434411	14.371150676277136	KRT8
Fetal Growth Retardation	1/304	0.1420430480181535	0.1528990084099645	0	0	7.219288595526219	14.089344915722105	APOE
Lupus Erythematosus	1/304	0.1420430480181535	0.1528990084099645	0	0	7.219288595526219	14.089344915722105	MFGE8
Malignant neoplasm of skin	1/307	0.14334924783979341	0.15402138853374864	0	0	7.147421931735657	13.883662212153366	LGALS3
Serum total cholesterol measurement	1/307	0.14334924783979341	0.15402138853374864	0	0	7.147421931735657	13.883662212153366	APOE
Lupus Erythematosus, Discoid	1/309	0.1442190531242349	0.15467162669929416	0	0	7.1002886002886	13.749154576304011	MFGE8
Peripheral Neuropathy	1/309	0.1442190531242349	0.15467162669929416	0	0	7.1002886002886	13.749154576304011	APOE
Hepatitis	1/317	0.14769033146960184	0.15810439330399684	0	0	6.917721518987341	13.231093952779949	APOE
Psychotic Disorders	1/317	0.14769033146960184	0.15810439330399684	0	0	6.917721518987341	13.231093952779949	APOE
Barrett Esophagus	1/323	0.15028546837258855	0.160588402676011	0	0	6.786749482401656	12.862374334753984	CTSD
Kaposi Sarcoma	1/323	0.15028546837258855	0.160588402676011	0	0	6.786749482401656	12.862374334753984	LGALS3
High density lipoprotein measurement	1/324	0.15071729911795276	0.16090276042820711	0	0	6.765393876848985	12.802488963649255	APOE
Impaired glucose tolerance	1/326	0.15158036808633552	0.16167650574172102	0	0	6.723076923076923	12.68402122249695	APOE
Mental disorders	1/329	0.1528734915506339	0.16275875375472773	0	0	6.6605691056910565	12.509511580612491	APOE
Primary biliary cirrhosis	1/329	0.1528734915506339	0.16275875375472773	0	0	6.6605691056910565	12.509511580612491	APOE
Broad flat nasal bridge	1/330	0.15330413834941983	0.16306873314874593	0	0	6.639986491050321	12.452175815383976	CTSD
Nasal bridge wide	1/333	0.1545948968175073	0.16429221307242367	0	0	6.578982597054886	12.282612824708192	CTSD
Graves Disease	1/335	0.15545441833302373	0.16505559948347387	0	0	6.538922155688622	12.171567486630012	HSPA1A
Mood Disorders	1/336	0.15588388409564177	0.16521147824823684	0	0	6.519071310116086	12.116632004300358	APOE
Triglycerides measurement	1/336	0.15588388409564177	0.16521147824823684	0	0	6.519071310116086	12.116632004300358	APOE
Pneumonitis	1/339	0.15717110230149295	0.16642483567975114	0	0	6.460223537146614	11.954128410568165	HSPA1A
Adenocarcinoma of pancreas	1/354	0.16358073307203908	0.17305509227259155	0	0	6.180988353792887	11.1903618987592	PLAU
Retinal Diseases	1/355	0.16400647782231223	0.1733486189640895	0	0	6.163214061519146	11.142162553650168	APOE
Precursor B-cell lymphoblastic leukemia	1/367	0.1691002237169371	0.17857105828825603	0	0	5.957498482088646	10.588045795572027	LGALS3
Abnormal behavior	1/372	0.17121436096224613	0.18064042235096184	0	0	5.87571129080563	10.369684054878048	APOE
Hepatomegaly	1/373	0.17163660699766897	0.18092262721395405	0	0	5.859617682198327	10.32684832527976	APOE
Calcification of coronary artery	1/375	0.17248051825613087	0.1816484016589342	0	0	5.827688651218063	10.241993723070818	APOE
Glaucoma	1/381	0.17500761149133715	0.18414392244228003	0	0	5.733918128654971	9.993793908998693	APOE
Anxiety Disorders	1/396	0.1812949856052708	0.1905879839681309	0	0	5.5119549929676515	9.412378710285338	APOE
Rhabdomyosarcoma	1/397	0.18171260644912532	0.19085537910065364	0	0	5.497755331088665	9.375481190982965	PLAU
Retinitis Pigmentosa	1/410	0.1871242580109411	0.1963628883436177	0	0	5.319478402607987	8.915352187694122	CTSD
Myopathy	1/415	0.18919707070735828	0.19835997816762496	0	0	5.253891572732153	8.747551387962368	APOE
Cardiomyopathy, Dilated	1/419	0.1908518944356418	0.19991564927891153	0	0	5.202551834130782	8.616765876979299	LGALS3
Benign Prostatic Hyperplasia	1/420	0.19126512511998253	0.20016914168778835	0	0	5.18987006099178	8.584536685135152	HSPA1A
Alcoholic Intoxication, Chronic	1/424	0.19291614922147857	0.2017164386761256	0	0	5.139742579458892	8.457444587190968	APOE
Inflammation	1/429	0.1949756632231477	0.20368771251819454	0	0	5.078400830737279	8.30257865283454	PLAU
nervous system disorder	1/436	0.19785103670528198	0.20632280277294796	0	0	4.9948914431673055	8.092927263974172	APOE
Dementia	1/436	0.19785103670528198	0.20632280277294796	0	0	4.9948914431673055	8.092927263974172	APOE
Osteoporosis	1/441	0.19989921224329585	0.2082728869094589	0	0	4.936868686868687	7.948072140035872	APOE
Anxiety	1/464	0.2092603297564428	0.21783199063693823	0	0	4.686105111591073	7.329894110658117	APOE
Epileptic encephalopathy	1/468	0.2108782501195694	0.21912593279091255	0	0	4.645015465143945	7.229847313947393	CTSD
Septicemia	1/468	0.2108782501195694	0.21912593279091255	0	0	4.645015465143945	7.229847313947393	MFGE8
Malaria	1/469	0.21128226438935221	0.2193507700454287	0	0	4.634852801519468	7.205158131783148	APOE
Malignant Head and Neck Neoplasm	1/470	0.21168609248829842	0.21957501518972572	0	0	4.6247334754797444	7.180596118620582	PLAU
Lip and Oral Cavity Carcinoma	1/473	0.21289646054063843	0.2206347184148992	0	0	4.594632768361582	7.1076640927494825	PLAU
Acute Promyelocytic Leukemia	1/475	0.21370244310536404	0.22127383170077108	0	0	4.574777308954524	7.0596622304501	LGALS3
Dermatitis, Atopic	1/484	0.2173201805667449	0.2248206115774556	0	0	4.487462617897401	6.849589015382386	PLAU
Malignant neoplasm of mouth	1/492	0.2205233633620704	0.22793263640164482	0	0	4.412536773025572	6.670659674136806	PLAU
Renal carcinoma	1/500	0.22371474296156477	0.2310269739594251	0	0	4.34001336005344	6.498664428104614	PLAU
Myeloid Leukemia	1/501	0.22411283742595428	0.2312338101950049	0	0	4.331111111111111	6.47763409892443	PLAU
Malignant neoplasm of thyroid	1/505	0.22570337858788686	0.2326695322480068	0	0	4.295855379188713	6.394525183908231	LGALS3
Cataract	1/519	0.23124719036074087	0.23817441897066613	0	0	4.176748176748177	6.115878918361201	APOE
Hepatocarcinogenesis	1/527	0.23439901905375046	0.2412081454875302	0	0	4.111533586818758	5.964726790561129	PLAU
Sepsis	1/529	0.23518515676747076	0.2418042640819466	0	0	4.095538720538721	5.927809736751767	MFGE8
Metastatic Neoplasm	1/544	0.24105807134623103	0.2476246796166468	0	0	3.9793329240843054	5.661466249485598	LGALS3
Hematologic Neoplasms	1/557	0.24611506552664603	0.2525974640918781	0	0	3.883693045563549	5.4447671804773465	LGALS3
Cerebellar Ataxia	1/565	0.2492119681124256	0.2555515708100224	0	0	3.827029156816391	5.317471276529871	CTSD
Small head	1/570	0.2511417131574491	0.2573046999833988	0	0	3.792423354813513	5.240135100853255	CTSD
Mental Depression	1/575	0.25306699305090163	0.2588235475734943	0	0	3.758420441347271	5.164449402029751	APOE
Diffuse Large B-Cell Lymphoma	1/575	0.25306699305090163	0.2588235475734943	0	0	3.758420441347271	5.164449402029751	LGALS3
Influenza	1/589	0.258434100250669	0.2640816985953077	0	0	3.6662887377173092	4.960908631349601	IFITM3
Medulloblastoma	1/590	0.2588161335460576	0.264241100537416	0	0	3.6598754951895867	4.946824519866452	PLAU
Hodgkin Disease	1/592	0.2595796688538885	0.2647893829757379	0	0	3.6471141191953373	4.918832229402382	APOE
Liver and Intrahepatic Biliary Tract Carcinoma	1/607	0.265283657020915	0.2703719224563641	0	0	3.554088742207554	4.716118036198457	PLAU
Colitis	1/608	0.2656625129438193	0.2705221930586453	0	0	3.5480505216913785	4.7030421713594555	KRT8
Precursor Cell Lymphoblastic Leukemia Lymphoma	1/618	0.26944141367920077	0.2741314295831033	0	0	3.4887448226184046	4.575154966209169	LGALS3
Huntington Disease	1/627	0.2728274506267645	0.2773350345936415	0	0	3.4369897053603125	4.464360001113019	APOE
Arthritis	1/630	0.2739529868050031	0.27823722117727945	0	0	3.420067125949479	4.428298702249088	LGALS3
Sarcoma	1/658	0.28438263041490475	0.28857924909290245	0	0	3.269575511584644	4.111277563281193	PLAU
Chronic Obstructive Airway Disease	1/669	0.28844295908509254	0.2924456367480253	0	0	3.213905522288756	3.99571352061664	PLAU
Impaired cognition	1/671	0.28917896900308154	0.29293779442339885	0	0	3.2039800995024876	3.9752085877342163	APOE
Malignant neoplasm of esophagus	1/673	0.28991429366554217	0.2934284063160336	0	0	3.1941137566137567	3.954855634438848	LGALS3
Esophageal carcinoma	1/685	0.29431188329558017	0.29762161900738165	0	0	3.136127355425601	3.835845183033585	LGALS3
Hyperactive behavior	1/709	0.30303360546523744	0.3061765642081785	0	0	3.0260514752040177	3.6128378691641827	APOE
Thyroid carcinoma	1/721	0.30735798085543686	0.3102776162521638	0	0	2.9737654320987654	3.5082764223727647	LGALS3
B-Cell Lymphomas	1/730	0.31058539896078313	0.3132651694436199	0	0	2.9356805365035816	3.4326806198064603	LGALS3
Depressive disorder	1/741	0.31451163732753357	0.3169518138240403	0	0	2.8903903903903903	3.3434134185026854	APOE
Solid Neoplasm	1/840	0.34895262722028336	0.35135712422093995	0	0	2.536220368163157	2.670181257120579	PLAU
Glioblastoma Multiforme	1/854	0.35369524986103545	0.3558259441373068	0	0	2.4927706135209067	2.590785388628805	PLAU
Myeloid Leukemia, Chronic	1/876	0.3610851454407928	0.36294800947574096	0	0	2.4273015873015873	2.4725501019589684	LGALS3
Intellectual Disability	2/2503	0.36169345872493763	0.36324712478475263	0	0	1.7482007197121152	1.777847100854535	APOE;CTSD
Acute lymphocytic leukemia	1/907	0.3713691181112016	0.3726442052120126	0	0	2.3404464066715724	2.3183497453543334	LGALS3
Squamous cell carcinoma of the head and neck	1/934	0.380204479173796	0.38118270682175603	0	0	2.2695010122662858	2.1947120300033687	LGALS3
Squamous cell carcinoma of esophagus	1/1023	0.4085427666571727	0.4092429256403041	0	0	2.062187432050446	1.845984975921689	PLAU
Chronic Lymphocytic Leukemia	1/1120	0.43809561975097894	0.4384707016172041	0	0	1.8737960480587827	1.546477761376383	APOE
Mental Retardation	1/1158	0.449305878762793	0.449305878762793	0	0	1.808604628829348	1.4469766268560906	APOE
